{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "os.environ['CUDA_DEVICE_ORDER']='PCI_BUS_ID'\n",
    "os.environ['CUDA_VISIBLE_DEVICES']='4,5,6,7'\n",
    "import gc\n",
    "import re\n",
    "import json\n",
    "import torch\n",
    "import pickle\n",
    "import string\n",
    "import argparse\n",
    "import subprocess\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "from scipy.special import softmax\n",
    "from collections import OrderedDict\n",
    "from vllm import LLM, SamplingParams\n",
    "from sklearn.neighbors import NearestNeighbors\n",
    "from sklearn.model_selection import StratifiedKFold\n",
    "from transformers import AutoTokenizer, AutoModel, AutoModelForCausalLM, AutoConfig\n",
    "from sklearn.metrics import accuracy_score, roc_auc_score, precision_score, recall_score, f1_score"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Load pipeline arguments\n",
    "---"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Data files\n",
    "examples_arg = '../../example_file.csv'\n",
    "test_data_arg = '../../test_file.csv'\n",
    "\n",
    "examples_summary_arg = '../../example_summary_file.csv'\n",
    "test_data_summary_arg = '../../test_summary_file.csv'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Run the pipeline - 8B Experiments\n",
    "---"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Zero-Shot Full Notes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "!/home/srinivasb/.conda/envs/radoncB/bin/python3 run_dynamic_prompt.py \\\n",
    "    --exp_type zero_shot_fn \\\n",
    "    --large False \\\n",
    "    --num_gpus 4 \\\n",
    "    --zero_shot True \\\n",
    "    --examples ../../example_file.csv \\\n",
    "    --test_data ../../test_file.csv \\\n",
    "    --summary False"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Zero Shot Summary Notes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting script execution...\n",
      "\n",
      "Processing data...\n",
      "Loaded 378 examples and 97 test samples.\n",
      "\n",
      "Loading embedding model...\n",
      "Creating vector database...\n",
      "Generating embeddings: 100%|██████████████████| 378/378 [00:37<00:00, 10.18it/s]\n",
      "Vector database created successfully.\n",
      "\n",
      "Initializing LLM model...\n",
      "INFO 02-21 12:08:08 config.py:890] Defaulting to use mp for distributed inference\n",
      "WARNING 02-21 12:08:08 arg_utils.py:862] Chunked prefill is enabled by default for models with max_model_len > 32K. Currently, chunked prefill might not work with some features or models. If you encounter any issues, please disable chunked prefill by setting --enable-chunked-prefill=False.\n",
      "INFO 02-21 12:08:08 config.py:999] Chunked prefill is enabled with max_num_batched_tokens=512.\n",
      "INFO 02-21 12:08:08 llm_engine.py:213] Initializing an LLM engine (v0.6.0) with config: model='gradientai/Llama-3-8B-Instruct-262k', speculative_config=None, tokenizer='gradientai/Llama-3-8B-Instruct-262k', skip_tokenizer_init=False, tokenizer_mode=auto, revision=None, override_neuron_config=None, rope_scaling=None, rope_theta=None, tokenizer_revision=None, trust_remote_code=False, dtype=torch.bfloat16, max_seq_len=262144, download_dir=None, load_format=LoadFormat.AUTO, tensor_parallel_size=4, pipeline_parallel_size=1, disable_custom_all_reduce=False, quantization=None, enforce_eager=False, kv_cache_dtype=auto, quantization_param_path=None, device_config=cuda, decoding_config=DecodingConfig(guided_decoding_backend='outlines'), observability_config=ObservabilityConfig(otlp_traces_endpoint=None, collect_model_forward_time=False, collect_model_execute_time=False), seed=0, served_model_name=gradientai/Llama-3-8B-Instruct-262k, use_v2_block_manager=False, num_scheduler_steps=1, enable_prefix_caching=False, use_async_output_proc=True)\n",
      "WARNING 02-21 12:08:08 multiproc_gpu_executor.py:56] Reducing Torch parallelism from 48 threads to 1 to avoid unnecessary CPU contention. Set OMP_NUM_THREADS in the external environment to tune this value as needed.\n",
      "INFO 02-21 12:08:08 custom_cache_manager.py:17] Setting Triton cache manager to: vllm.triton_utils.custom_cache_manager:CustomCacheManager\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:09 multiproc_worker_utils.py:215] Worker ready; awaiting tasks\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m INFO 02-21 12:08:09 multiproc_worker_utils.py:215] Worker ready; awaiting tasks\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:09 multiproc_worker_utils.py:215] Worker ready; awaiting tasks\n",
      "INFO 02-21 12:08:10 utils.py:977] Found nccl from library libnccl.so.2\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:10 utils.py:977] Found nccl from library libnccl.so.2\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m INFO 02-21 12:08:10 utils.py:977] Found nccl from library libnccl.so.2\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:10 utils.py:977] Found nccl from library libnccl.so.2\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:10 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "INFO 02-21 12:08:10 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m \u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:10 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "INFO 02-21 12:08:10 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "WARNING 02-21 12:08:11 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m WARNING 02-21 12:08:11 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m WARNING 02-21 12:08:11 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m WARNING 02-21 12:08:11 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "INFO 02-21 12:08:11 shm_broadcast.py:235] vLLM message queue communication handle: Handle(connect_ip='127.0.0.1', local_reader_ranks=[1, 2, 3], buffer=<vllm.distributed.device_communicators.shm_broadcast.ShmRingBuffer object at 0x7fa45adaa2d0>, local_subscribe_port=45241, remote_subscribe_port=None)\n",
      "INFO 02-21 12:08:11 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:11 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m \u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:11 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "INFO 02-21 12:08:11 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "INFO 02-21 12:08:12 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:12 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m INFO 02-21 12:08:12 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:12 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "Loading safetensors checkpoint shards:   0% Completed | 0/4 [00:00<?, ?it/s]\n",
      "Loading safetensors checkpoint shards:  50% Completed | 2/4 [00:00<00:00,  4.06it/s]\n",
      "Loading safetensors checkpoint shards:  75% Completed | 3/4 [00:01<00:00,  2.70it/s]\n",
      "Loading safetensors checkpoint shards: 100% Completed | 4/4 [00:01<00:00,  2.32it/s]\n",
      "Loading safetensors checkpoint shards: 100% Completed | 4/4 [00:01<00:00,  2.55it/s]\n",
      "\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:14 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "INFO 02-21 12:08:14 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:14 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m INFO 02-21 12:08:14 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "INFO 02-21 12:08:15 distributed_gpu_executor.py:57] # GPU blocks: 75857, # CPU blocks: 8192\n",
      "INFO 02-21 12:08:18 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "INFO 02-21 12:08:18 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:18 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:18 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m INFO 02-21 12:08:18 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m INFO 02-21 12:08:18 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:18 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:18 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490507)\u001b[0;0m INFO 02-21 12:08:31 model_runner.py:1335] Graph capturing finished in 13 secs.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490509)\u001b[0;0m INFO 02-21 12:08:31 model_runner.py:1335] Graph capturing finished in 13 secs.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=490508)\u001b[0;0m INFO 02-21 12:08:31 model_runner.py:1335] Graph capturing finished in 13 secs.\n",
      "INFO 02-21 12:08:31 model_runner.py:1335] Graph capturing finished in 13 secs.\n",
      "Loaded LLM model: gradientai/Llama-3-8B-Instruct-262k\n",
      "\n",
      "Starting model evaluation...\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 10.18it/s, est. speed input: 3865.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.68it/s, est. speed input: 6212.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.68it/s, est. speed input: 6157.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.29it/s, est. speed input: 6444.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.95it/s, est. speed input: 6215.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.59it/s, est. speed input: 6437.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.37it/s, est. speed input: 6286.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.19it/s, est. speed input: 7087.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.21it/s, est. speed input: 6615.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.35it/s, est. speed input: 6447.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.29it/s, est. speed input: 6384.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.08it/s, est. speed input: 6713.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.54it/s, est. speed input: 6302.3\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.79it/s, est. speed input: 6730.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.53it/s, est. speed input: 6244.4\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.74it/s, est. speed input: 6883.4\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.17it/s, est. speed input: 6418.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.51it/s, est. speed input: 6705.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.59it/s, est. speed input: 6399.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.94it/s, est. speed input: 7106.3\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.30it/s, est. speed input: 6173.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.12it/s, est. speed input: 6683.5\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.28it/s, est. speed input: 6521.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 19.02it/s, est. speed input: 6205.5\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.43it/s, est. speed input: 6350.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.87it/s, est. speed input: 6779.4\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.46it/s, est. speed input: 6430.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.59it/s, est. speed input: 6512.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.28it/s, est. speed input: 6536.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.48it/s, est. speed input: 6381.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.09it/s, est. speed input: 6705.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.39it/s, est. speed input: 6403.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.94it/s, est. speed input: 6983.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.81it/s, est. speed input: 6138.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.16it/s, est. speed input: 6342.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.05it/s, est. speed input: 6739.3\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.64it/s, est. speed input: 6425.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.52it/s, est. speed input: 6357.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.62it/s, est. speed input: 6646.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.60it/s, est. speed input: 6534.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.48it/s, est. speed input: 6629.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.87it/s, est. speed input: 6231.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.40it/s, est. speed input: 6444.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.72it/s, est. speed input: 6555.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.74it/s, est. speed input: 6427.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.10it/s, est. speed input: 6862.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.60it/s, est. speed input: 6991.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.87it/s, est. speed input: 6989.3\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.77it/s, est. speed input: 6479.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.24it/s, est. speed input: 6882.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.98it/s, est. speed input: 6932.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.99it/s, est. speed input: 6591.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.72it/s, est. speed input: 6643.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.50it/s, est. speed input: 6304.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.93it/s, est. speed input: 6389.4\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.01it/s, est. speed input: 6523.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.27it/s, est. speed input: 6437.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.03it/s, est. speed input: 7396.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.75it/s, est. speed input: 6922.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.43it/s, est. speed input: 6272.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.87it/s, est. speed input: 6419.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.07it/s, est. speed input: 6730.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.32it/s, est. speed input: 6726.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.29it/s, est. speed input: 7011.3\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.09it/s, est. speed input: 6483.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.56it/s, est. speed input: 6661.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.40it/s, est. speed input: 6876.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.91it/s, est. speed input: 6854.4\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.18it/s, est. speed input: 6603.5\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.41it/s, est. speed input: 7061.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.54it/s, est. speed input: 6215.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.37it/s, est. speed input: 6270.5\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.78it/s, est. speed input: 6390.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.80it/s, est. speed input: 6432.5\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.14it/s, est. speed input: 6609.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.13it/s, est. speed input: 6718.3\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.80it/s, est. speed input: 6453.8\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.46it/s, est. speed input: 6206.4\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.24it/s, est. speed input: 6408.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.29it/s, est. speed input: 6864.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.83it/s, est. speed input: 5748.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.07it/s, est. speed input: 6418.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.86it/s, est. speed input: 6469.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.55it/s, est. speed input: 6032.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.74it/s, est. speed input: 6095.0\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.91it/s, est. speed input: 6550.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.60it/s, est. speed input: 7392.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.29it/s, est. speed input: 6114.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.53it/s, est. speed input: 6453.3\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.72it/s, est. speed input: 6743.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.07it/s, est. speed input: 6782.6\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.27it/s, est. speed input: 6471.1\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.42it/s, est. speed input: 6560.9\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.21it/s, est. speed input: 6470.2\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 16.73it/s, est. speed input: 7200.4\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 17.77it/s, est. speed input: 6332.7\n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00, 18.71it/s, est. speed input: 6348.3\n",
      "Computing evaluation metrics...\n",
      "Evaluation complete. Metrics:\n",
      "  - Accuracy: 0.6804\n",
      "  - Precision: 0.8537\n",
      "  - Recall: 0.5833\n",
      "  - F1 Score: 0.6931\n",
      "  - AUC: 0.7811\n",
      "\n",
      "Metrics saved to evaluation_metrics_0_shot_summary.txt\n",
      "Script execution finished successfully.\n",
      "ERROR 02-21 12:08:38 multiproc_worker_utils.py:120] Worker VllmWorkerProcess pid 490508 died, exit code: -15\n",
      "INFO 02-21 12:08:38 multiproc_worker_utils.py:123] Killing local vLLM worker processes\n"
     ]
    }
   ],
   "source": [
    "!/home/srinivasb/.conda/envs/radoncB/bin/python3 run_dynamic_prompt.py \\\n",
    "    --exp_type zero_shot_summary \\\n",
    "    --large False \\\n",
    "    --num_gpus 4 \\\n",
    "    --zero_shot True \\\n",
    "    --examples ../../example_summary_file.csv \\\n",
    "    --test_data ../../test_summary_file.csv \\\n",
    "    --summary True"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Dynamic Full Notes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "!/home/srinivasb/.conda/envs/radoncB/bin/python3 run_dynamic_prompt.py \\\n",
    "    --exp_type dynamic_fn \\\n",
    "    --large False \\\n",
    "    --num_gpus 4 \\\n",
    "    --zero_shot False \\\n",
    "    --examples ../../example_file.csv \\\n",
    "    --test_data ../../test_file.csv \\\n",
    "    --summary False"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Dynamic Summary Notes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Starting script execution...\n",
      "\n",
      "Processing data...\n",
      "Loaded 378 examples and 97 test samples.\n",
      "\n",
      "Loading embedding model...\n",
      "\n",
      "Creating vector database...\n",
      "Generating embeddings: 100%|██████████████████| 378/378 [00:38<00:00,  9.69it/s]\n",
      "Vector database created successfully.\n",
      "\n",
      "Initializing LLM model...\n",
      "INFO 02-21 13:46:34 config.py:890] Defaulting to use mp for distributed inference\n",
      "WARNING 02-21 13:46:34 arg_utils.py:862] Chunked prefill is enabled by default for models with max_model_len > 32K. Currently, chunked prefill might not work with some features or models. If you encounter any issues, please disable chunked prefill by setting --enable-chunked-prefill=False.\n",
      "INFO 02-21 13:46:34 config.py:999] Chunked prefill is enabled with max_num_batched_tokens=512.\n",
      "INFO 02-21 13:46:34 llm_engine.py:213] Initializing an LLM engine (v0.6.0) with config: model='gradientai/Llama-3-8B-Instruct-262k', speculative_config=None, tokenizer='gradientai/Llama-3-8B-Instruct-262k', skip_tokenizer_init=False, tokenizer_mode=auto, revision=None, override_neuron_config=None, rope_scaling=None, rope_theta=None, tokenizer_revision=None, trust_remote_code=False, dtype=torch.bfloat16, max_seq_len=262144, download_dir=None, load_format=LoadFormat.AUTO, tensor_parallel_size=4, pipeline_parallel_size=1, disable_custom_all_reduce=False, quantization=None, enforce_eager=False, kv_cache_dtype=auto, quantization_param_path=None, device_config=cuda, decoding_config=DecodingConfig(guided_decoding_backend='outlines'), observability_config=ObservabilityConfig(otlp_traces_endpoint=None, collect_model_forward_time=False, collect_model_execute_time=False), seed=0, served_model_name=gradientai/Llama-3-8B-Instruct-262k, use_v2_block_manager=False, num_scheduler_steps=1, enable_prefix_caching=False, use_async_output_proc=True)\n",
      "WARNING 02-21 13:46:35 multiproc_gpu_executor.py:56] Reducing Torch parallelism from 48 threads to 1 to avoid unnecessary CPU contention. Set OMP_NUM_THREADS in the external environment to tune this value as needed.\n",
      "INFO 02-21 13:46:35 custom_cache_manager.py:17] Setting Triton cache manager to: vllm.triton_utils.custom_cache_manager:CustomCacheManager\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "huggingface/tokenizers: The current process just got forked, after parallelism has already been used. Disabling parallelism to avoid deadlocks...\n",
      "To disable this warning, you can either:\n",
      "\t- Avoid using `tokenizers` before the fork if possible\n",
      "\t- Explicitly set the environment variable TOKENIZERS_PARALLELISM=(true | false)\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:35 multiproc_worker_utils.py:215] Worker ready; awaiting tasks\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:46:35 multiproc_worker_utils.py:215] Worker ready; awaiting tasks\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m INFO 02-21 13:46:35 multiproc_worker_utils.py:215] Worker ready; awaiting tasks\n",
      "INFO 02-21 13:46:37 utils.py:977] Found nccl from library libnccl.so.2\n",
      "INFO 02-21 13:46:37 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:37 utils.py:977] Found nccl from library libnccl.so.2\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m \u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m INFO 02-21 13:46:37 utils.py:977] Found nccl from library libnccl.so.2\n",
      "INFO 02-21 13:46:37 utils.py:977] Found nccl from library libnccl.so.2\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:37 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:46:37 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m INFO 02-21 13:46:37 pynccl.py:63] vLLM is using nccl==2.20.5\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m WARNING 02-21 13:46:37 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m WARNING 02-21 13:46:37 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m WARNING 02-21 13:46:37 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "WARNING 02-21 13:46:37 custom_all_reduce.py:122] Custom allreduce is disabled because it's not supported on more than two PCIe-only GPUs. To silence this warning, specify disable_custom_all_reduce=True explicitly.\n",
      "INFO 02-21 13:46:38 shm_broadcast.py:235] vLLM message queue communication handle: Handle(connect_ip='127.0.0.1', local_reader_ranks=[1, 2, 3], buffer=<vllm.distributed.device_communicators.shm_broadcast.ShmRingBuffer object at 0x7ff0b3236690>, local_subscribe_port=33173, remote_subscribe_port=None)\n",
      "INFO 02-21 13:46:38 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:38 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m INFO 02-21 13:46:38 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:46:38 model_runner.py:915] Starting to load model gradientai/Llama-3-8B-Instruct-262k...\n",
      "INFO 02-21 13:46:38 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:38 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:46:38 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m INFO 02-21 13:46:38 weight_utils.py:236] Using model weights format ['*.safetensors']\n",
      "Loading safetensors checkpoint shards:   0% Completed | 0/4 [00:00<?, ?it/s]\n",
      "Loading safetensors checkpoint shards:  50% Completed | 2/4 [00:00<00:00,  5.35it/s]\n",
      "Loading safetensors checkpoint shards:  75% Completed | 3/4 [00:00<00:00,  3.51it/s]\n",
      "Loading safetensors checkpoint shards: 100% Completed | 4/4 [00:01<00:00,  2.96it/s]\n",
      "Loading safetensors checkpoint shards: 100% Completed | 4/4 [00:01<00:00,  3.27it/s]\n",
      "\n",
      "INFO 02-21 13:46:40 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:40 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:46:41 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m INFO 02-21 13:46:41 model_runner.py:926] Loading model weights took 3.8023 GB\n",
      "INFO 02-21 13:46:42 distributed_gpu_executor.py:57] # GPU blocks: 61284, # CPU blocks: 8192\n",
      "INFO 02-21 13:46:45 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "INFO 02-21 13:46:45 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:46:45 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:46:45 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m \u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:45 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "INFO 02-21 13:46:45 model_runner.py:1217] Capturing the model for CUDA graphs. This may lead to unexpected consequences if the model is not static. To run the model in eager mode, set 'enforce_eager=True' or use '--enforce-eager' in the CLI.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m \u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:46:45 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "INFO 02-21 13:46:45 model_runner.py:1221] CUDA graphs can take additional 1~3 GiB memory per GPU. If you are running out of memory, consider decreasing `gpu_memory_utilization` or enforcing eager mode. You can also reduce the `max_num_seqs` as needed to decrease memory usage.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513349)\u001b[0;0m INFO 02-21 13:47:01 model_runner.py:1335] Graph capturing finished in 16 secs.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513351)\u001b[0;0m INFO 02-21 13:47:01 model_runner.py:1335] Graph capturing finished in 16 secs.\n",
      "INFO 02-21 13:47:01 model_runner.py:1335] Graph capturing finished in 16 secs.\n",
      "\u001b[1;36m(VllmWorkerProcess pid=513350)\u001b[0;0m INFO 02-21 13:47:01 model_runner.py:1335] Graph capturing finished in 16 secs.\n",
      "Loaded LLM model: gradientai/Llama-3-8B-Instruct-262k\n",
      "\n",
      "Starting model evaluation...\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [60-70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the right medial frontal gyrus and gyrus rectus along the posterior and inferior resection margins].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left frontal lobe, involving the genu of the corpus callosum and extending into the right frontal and right parietal white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [Left Frontal Lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Left Frontal Lobe extending to the genu of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal region], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [80 initially, later 90, and at the end 80 again].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [bilateral frontal lobes, left greater than right, with increased thickness of enhancement and increase in the FLAIR signal surrounding the resection cavity consistent with post-radiation effects].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior insular and inferior frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula, left inferior frontal lobe, head of the left hippocampus, the left amygdala, the left anterior perforating substance as well as left basal ganglia, extending through the genu of the corpus callosum to involve the contralateral side of the genu].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending into the parietal region], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [80 to 90, as it improved over time].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [46 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] in the form of [Avastin].\n",
      "\n",
      "The patient's response to treatment has been [Improvement], with tumor progression being [Noted], occurring at [left frontal lobe, specifically the postcentral gyrus and precentral gyrus inferiorly in the frontal operculum].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  3.89it/s, est. speed input: 8047.7\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right frontal lobe, and is characterized as Glioblastoma, WHO grade IV. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 50, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Stable, with tumor progression being Noted, occurring at Right posterior frontal and temporal lobes.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma with giant cell features, likely IDH-wildtype]. The tumor measures [5.0 x 4.4 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion (loss of chromosome 10) is also [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [not specified].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right inferior frontal lobe, and is characterized as Glioblastoma. The tumor measures 2.4 x 1.8 x 2.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 51, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of wildtype, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification Present. The patient had a biopsy, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been significant response, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right frontal lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 19, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Wildtype, MGMT promoter methylation status of Methylated, 1p/19q co-deletion Absent, ATRX status of Retained, TERT promoter mutation Present, and EGFR amplification Absent. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Partial response to treatment, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Frontal region, and is characterized as Glioblastoma WHO grade-4. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 44 years, and Karnofsky Performance Status (KPS) is 70. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Probable, occurring at new regions of enhancement and increased T-2 FLAIR in the right frontal region and new expansile FLAIR signal hyperintensity in the left superior parietal lobe.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the right inferior frontal lobe, insula, and white matter, and is characterized as giant cell glioblastoma, WHO grade IV. The tumor measures not specified, with a grade of not specified. The WHO grade is IV. The patient's age is 76, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified.\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at multiple small enhancing nodules medial, superior, inferior to the right frontal resection cavity, as well as additional nodules in the right and left frontal lobes.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.17it/s, est. speed input: 9717.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the parieto-occipital lobe, and is characterized as Glioblastoma. The tumor measures 6.1 x 4.5 x 5.2 cm, with a grade of IV. The WHO grade is IV. The patient's age is 34, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion Not Specified, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Absent.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the resection cavity with increased peripheral enhancement and enlargement of the right parietal resection cavity, with increased T2/FLAIR signal abnormality compared to MRI from previous dates.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.9 x 2.5 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right parieto-occipital lobes, right frontal lobe, and right cerebellum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.1 x 2.6 x 2.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Present], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [anterior aspect of resection cavity and right occipital lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.7 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [85 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [No evidence of disease progression], with tumor progression being [Absent], occurring at [Not specified].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.6 x 3.5 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present with a relative copy gain].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used in the form of an investigational vaccine as part of the ACT IV CDX trial].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Probable], occurring at [right posterior parietal white matter and nodular area of enhancement in right postcentral gyrus adjacent to the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the Right Parietal and Occipital Lobe, and is characterized as Glioblastoma. The tumor measures 5.8 x 5.3 x 4.0 cm, with a grade of IV. The WHO grade is IV. The patient's age is 73, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of [Not Specified], MGMT promoter methylation status of [Not Specified], 1p/19q co-deletion [Not Specified], ATRX status of [Not Specified], TERT promoter mutation [Not Specified], and EGFR amplification [Not Specified]. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not Specified] over [Not Specified] fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was [Not Specified]. The patient's response to treatment has been Stable Disease, with tumor progression being Absent, occurring at [Not Specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.03it/s, est. speed input: 10185.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe, extending into the right orbital frontal gyrus, white matter, and right temporal lobe], and is characterized as [Oligodendroglioma with focal aplastic features]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [41 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [tolerated the treatment quite well], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right Frontal Lobe], and is characterized as [Aplastic Oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, non-progressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior frontal gyrus], and is characterized as [Aplastic Oligodendroglioma]. The tumor measures [up to 5.5 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Present], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable disease], with tumor progression being [Noted], occurring at [right genu of the corpus callosum with minimal crossing of the midline leftward].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic Oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [33 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe extending through the temporal stem involve left anterior temporal lobe and across midline to involve the genu and rostrum of the corpus callosum and right frontal lobe as well as bilateral fornices], and is characterized as [Aplastic oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [43], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Response to therapy with decrease in mass effect and midline shift], with tumor progression being [Probable], occurring at [anterior corpus callosum and right inferior frontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right insula, extending through the temporal stem to involve the right hippocampus, and amygdala], and is characterized as [Aplastic Oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [32 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [5940 cGy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.94it/s, est. speed input: 9822.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Aplastic oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [42 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Left frontal craniotomy for tumor resection, awake speech mapping], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted/Absent/Probable], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior frontal gyrus], and is characterized as [Aplastic Oligodendroglioma]. The tumor measures [3.7 x 2.2 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable non-progressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic Oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [33 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right Frontal Lobe], and is characterized as [Aplastic Oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, non-progressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [36 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [not specified] fractions. Chemotherapy drug was [PCV (Procarbazine, Lomustine (CCNU), and Vincristine)] as per standard care, although the specific use in this case is not detailed in the notes provided.\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left anterior insula, left external capsule, and genu extending across midline].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Aplastic oligodendroglioma]. The tumor measures [Size not specified], with a grade of [Grade III]. The WHO grade is [III]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [Not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Present], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [the white matter of the left superior and middle frontal gyri].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.08it/s, est. speed input: 9967.4\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.9 x 2.5 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right parieto-occipital lobes, right frontal lobe, and right cerebellum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.1 x 2.6 x 2.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Present], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [anterior aspect of resection cavity and right occipital lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right parietal lobule], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Right parietal region extending into the right splenium of the corpus callosum and across to the left periventricular white matter].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the genu of the corpus callosum and extending to the subcortical frontal lobe white matter and temporal stem].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietotemporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right temporal lobe extending superiorly along the atrium of the right lateral ventricle, right interl and exterl capsules, right thalamus, midbrain, hypothalamus, and cerebral peduncle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [stable], with tumor progression being [Probable], occurring at [right superior frontal gyrus, callosal body and callosal genu].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.95it/s, est. speed input: 10030.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [41 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior to the right frontal resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the frontal lobe, and is characterized as Glioblastoma with some sarcomatous features. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 53, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Mutant (IDH-1 R132H mutant protein positive), MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Used (part of a phase 2 study with autologous heat shock protein vaccine). The patient's response to treatment has been stable, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the deep lateral aspect of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [wildtype], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not amplified in majority of cells].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Mixed response to therapy], with tumor progression being [Noted], occurring at [posterior left frontal lobe with surrounding FLAIR].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [50 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as part of a phase II heat shock protein vaccine study.\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Absent], occurring at [not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.11it/s, est. speed input: 9826.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right medial temporal lobe, insular region, and hippocampus], and is characterized as [Glioblastoma]. The tumor measures [3.9 x 3.4 x 3.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right medial temporal lobe, insular region, and hippocampus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [medial right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.6 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [78 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [posterior right parahippocampal gyrus and right amygdala].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left parahippocampal gyrus and hippocampus, left temporal stem and white matter, and left frontal lobe white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior temporal lobe including portions of the hippocampus], and is characterized as [Glioblastoma]. The tumor measures [2.3 x 3.6 x 3.9 cm (lat x AP x CC)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [51 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [posterior right fusiform temporal gyrus and right hippocampus], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion is also [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection of the posterior temporal region and a Subtotal Resection of the anterior temporal non-enhancing component], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 rads] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [medial temporal lobe extending to the upper midbrain, in the tectal region and more posteriorly to the thalamic area], and is characterized as [Glioblastoma with oligodendroglioma component]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [53 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [status is pending at the time of dictation], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the body and tail of the hippocampus, along the medial aspect of the resection cavity, with associated minimal increase in the extent of surrounding flair hyperintensity and subependymal enhancement in the right lateral ventricle].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.51it/s, est. speed input: 9413.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left basal ganglia and left dorsal thalamus], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 2.8 x 4.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [58], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Absent], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable disease], with tumor progression being [Probable], occurring at [left cerebral peduncle].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal and left parietal white matter, left basal ganglia, left internal capsule, anterior left temporal lobe, and brainstem], and is characterized as [Glioblastoma]. The tumor measures [1.9 x 1.9 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left basal ganglia, left internal capsule, anterior left temporal lobe, and brainstem].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left basal ganglia], and is characterized as [Glioblastoma, IDH-wildtype, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Left frontal burr hole for tumor biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [multifocal enhancing and non-enhancing disease in both hemispheres with the dominant mass in the L basal ganglia].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe and basal ganglia], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [72 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Left frontal craniotomy for open biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left frontal lobe and basal ganglia, with additional smaller abnormal enhancing regions in the right corona radiata as well as right precentral gyrus consistent with multifocal high grade glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending into the corpus callosum, right frontal white matter, left basal ganglia, left cerebral peduncle, and anterior centrum semiovale and corona radiata], and is characterized as [Glioblastoma]. The tumor measures [3.2 x 3.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left frontal lobe, extending into the corpus callosum and right frontal white matter, and inferiorly involving the posterior limb of the left internal capsule, left cerebral peduncle, and superior portion of the left pons].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left basal ganglia], and is characterized as [Glioblastoma]. The tumor measures [2.3 x 2.0 x 2.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent]. PTEN deletion was [Present] with a focal PTEN deletion and loss of chromosome 10.\n",
      "\n",
      "The patient had a [Left frontal burr hole for brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40.05 Gy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Response not clearly stated, but MRI findings suggest treatment response with decrease in size of the tumor], with tumor progression being [Not noted], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.52it/s, est. speed input: 9690.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [Retained], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right mesial temporal lobe, right lingual gyrus, right lateral occipital cortex, and right amygdala], and is characterized as [Infiltrating Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [74 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present with a ratio of EGFR to CEP7 of 1.19].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right amygdala and tail of hippocampus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe, motor cortex, and straddling the corpus callosum], and is characterized as [Aplastic Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [34 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [significant interval response to treatment manifested by markedly decreased masslike FLAIR abnormality], with tumor progression being [Probable], occurring at [precentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [anterior to the resection cavity in the insula and inferior frontal lobe and posterior to the cavity in the hippocampal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left middle frontal gyrus], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [36 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Loss], TERT promoter mutation [not specified], and EGFR amplification [not specified]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left middle frontal gyrus with residual nonenhancing tumor extending into the body of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right posterior frontal lobe, extending to the posterior frontal operculum and the supramarginal gyrus], and is characterized as [Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Noted], occurring at [right posterior frontal lobe].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.92it/s, est. speed input: 9885.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.9 x 6.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporopolar region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma (GBM)]. The tumor measures [7.8 x 5.6 x 4.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [posterior medial right temporal lobe, involving the posterior body and tail of the hippocampus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.9 x 4.6 x 4.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [75], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left medial temporal lobe concerning for nonenhancing glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe, right insula, right thalamus, and right corticospinal tract].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the anterior temporal lobe, and is characterized as Gliosarcoma. The tumor measures not specified, with a grade of not specified. The WHO grade is IV. The patient's age is 65 years, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified.\n",
      "\n",
      "The patient had a resection surgery, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the posterior aspect of the resection cavity as well as increasing extent of pericavity FLAIR signal abnormality.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Gliosarcoma]. The tumor measures [6.5 x 3.7 x 5.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as part of the BMS clinical trial.\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the site of residual post-operative enhancement along the posterior deep margin of the resection cavity].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.08it/s, est. speed input: 10032.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right lateral temporal lobe, predominantly involving the superior and middle temporal gyri], and is characterized as [Glioblastoma]. The tumor measures [6.5 x 5.1 x 5.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [73 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right temporal and insular white matter, centrum semi-ovale, right parietal subcortical white matter, and extending into the thalamus, right corticospinal tract, right optic tract and optic chiasm].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right medial temporal lobe, insular region, and hippocampus], and is characterized as [Glioblastoma]. The tumor measures [3.9 x 3.4 x 3.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right medial temporal lobe, insular region, and hippocampus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not detected], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Encouraging], with tumor progression being [Noted], occurring at [the right temporal stem and posterior aspect of the right insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe, right middle frontal gyrus, right anterior cingulate gyrus, and right temporal stem], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [72], and Karnofsky Performance Status (KPS) is [50]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right frontal periventricular and subcortical white matter, right anterior parietal white matter, right white matter, corpus callosum, anterior limb of the internal capsule, right caudate, bilateral thalami, pons, midbrain, right occipital and parietal white matter extending to the vertex].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe and right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Equivocal], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Right temporal craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right temporal lobe and right frontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right middle cranial fossa, right anterior temporal lobe, and insula], and is characterized as [Glioblastoma]. The tumor measures [6.9 x 5.8 x 5.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Partial Response], with tumor progression being [Probable], occurring at [right coro radiata white matter and opercularis subcortical white matter].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.55it/s, est. speed input: 9646.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe and right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Equivocal], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Right temporal craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right temporal lobe and right frontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe, right insula, right thalamus, and right corticospinal tract].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [medial right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.6 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [78 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [posterior right parahippocampal gyrus and right amygdala].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left parahippocampal gyrus and hippocampus, left temporal stem and white matter, and left frontal lobe white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right anterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.1 x 2.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [Right medial uncus and parahippocampal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Right temporal craniotomy for microsurgical resection of glioblastoma], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right medial temporal lobe including right hippocampus and parahippocampal gyrus].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.92it/s, est. speed input: 9835.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [80 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [unable to be determined], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN status is [deleted].\n",
      "\n",
      "The patient had a [right frontal craniotomy for resection of cystic glioblastoma with intraoperative motor mapping], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the right internal capsule and new nodular ependymal enhancement at the right frontal horn].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the deep lateral aspect of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the genu of the corpus callosum and extending to the subcortical frontal lobe white matter and temporal stem].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior frontal gyrus, extending into the anterior body of the corpus callosum and caudate head], and is characterized as [Glioblastoma]. The tumor measures [2.4 x 2.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe and extending into the anterior body of the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right posterior frontal periventricular white matter], and is characterized as [Glioblastoma]. The tumor measures [4.8 x 3.7 cm in largest axial dimension and 4.2 cm in largest craniocaudal dimension], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [72], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Right frontal craniotomy for resection of brain tumor under brain lab image guidance with intraoperative motor mapping], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted/Absent/Probable], occurring at [not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.90it/s, est. speed input: 9989.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [41 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior to the right frontal resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma, wildtype]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Not amplified].\n",
      "\n",
      "The patient had a [Near Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [5940 cGy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [inferior margin of the resection cavity with increased pericavity T2/FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [approximately 3.8 x 2.6 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [60-80, as it varied over the course of treatment].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4005 cGy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used, but discontinued after progression].\n",
      "\n",
      "The patient's response to treatment has been [Stable, treatment effects], with tumor progression being [Noted], occurring at [right posterior frontal resection cavity and surrounding areas].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right superior and middle frontal lobes], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 3.9 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [tolerated with minimal fatigue], with tumor progression being [Not noted/Absent/Probable], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.02it/s, est. speed input: 10040.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe, extending into the genu of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [90 initially, later 60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Suboptimal sample yielded low quality DNA, so status is not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used - the patient was on a vaccine trial].\n",
      "\n",
      "The patient's response to treatment has been [initially stable, later with signs of progression], with tumor progression being [Probable], occurring at [right caudate nucleus and left genu of corpus callosum with new infiltrative disease along the septum pellucidum and left column of fornix].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right cingulate gyrus extending along the lateral genu of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [2.1 cm (transverse) x 3.1 cm (AP) x 2.4 cm (CC)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe, with surrounding edema-like FLAIR, consistent with high-grade glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right cingulate gyrus and corpus callosum], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [2.2 cm TV x 1 cm AP x 1.6 cm SI], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [2 years], and Karnofsky Performance Status (KPS) is [100: Fully active].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)] and Vorinostat. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left callosal body at the resection margin].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior frontal gyrus, extending into the anterior body of the corpus callosum and caudate head], and is characterized as [Glioblastoma]. The tumor measures [2.4 x 2.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe and extending into the anterior body of the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior callosal body, right cingulate gyrus, and right superior and middle frontal gyri], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection] [not specified], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right callosal body, right cingulate gyrus, and right superior and middle frontal gyri].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right periventricular white matter, extending to the ependymal surface of the right lateral ventricle, as well as expanding and crossing the body of the corpus callosum and involving the septum pellucidum, right third cranial nerve, extending into the interpeduncular fossa and right anterior pons], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, biopsy only], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [improved disease based upon imaging], with tumor progression being [Probable], occurring at [anterior right corpus callosum extending across midline].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.31it/s, est. speed input: 9409.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.1 x 2.6 x 2.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Present], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [anterior aspect of resection cavity and right occipital lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.9 x 2.5 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right parieto-occipital lobes, right frontal lobe, and right cerebellum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietotemporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right temporal lobe extending superiorly along the atrium of the right lateral ventricle, right interl and exterl capsules, right thalamus, midbrain, hypothalamus, and cerebral peduncle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal and occipital lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Right parietal craniotomy for gross total resection of glioblastoma under image guidance], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as the patient was enrolled in a clinical trial of heat shock protein vaccine.\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right inferior parietal lobule, and the inferior right post and pre-central gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.6 x 3.5 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present with a relative copy gain].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used in the form of an investigational vaccine as part of the ACT IV CDX trial].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Probable], occurring at [right posterior parietal white matter and nodular area of enhancement in right postcentral gyrus adjacent to the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [parieto-occipital region], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 4 x 3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [81 years], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [bilateral superior frontal lobes, right temporal lobe].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.43it/s, est. speed input: 9248.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [approximately 3.8 x 2.6 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [60-80, as it varied over the course of treatment].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4005 cGy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used, but discontinued after progression].\n",
      "\n",
      "The patient's response to treatment has been [Stable, treatment effects], with tumor progression being [Noted], occurring at [right posterior frontal resection cavity and surrounding areas].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior frontal gyrus, extending into the anterior body of the corpus callosum and caudate head], and is characterized as [Glioblastoma]. The tumor measures [2.4 x 2.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe and extending into the anterior body of the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right cingulate gyrus extending along the lateral genu of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [2.1 cm (transverse) x 3.1 cm (AP) x 2.4 cm (CC)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe, with surrounding edema-like FLAIR, consistent with high-grade glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [posterior right fusiform and parahippocampal gyri], and is characterized as [Glioblastoma]. The tumor measures [3.5 x 3.0 x 2.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [51 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [improved], with tumor progression being [Noted], occurring at [resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right medial frontal gyrus], and is characterized as [Glioblastoma with giant cell features]. The tumor measures [3.0 x 1.6 x 2.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not amplified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [superior and lateral to the resection cavity].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.50it/s, est. speed input: 9325.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.9 x 6.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporopolar region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.9 x 4.6 x 4.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [75], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left medial temporal lobe concerning for nonenhancing glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe, right insula, right thalamus, and right corticospinal tract].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not detected], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Encouraging], with tumor progression being [Noted], occurring at [the right temporal stem and posterior aspect of the right insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [medial right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.6 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [78 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [posterior right parahippocampal gyrus and right amygdala].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [7.1 x 4.1 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Absent], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.07it/s, est. speed input: 9988.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe, right middle frontal gyrus, right anterior cingulate gyrus, and right temporal stem], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [72], and Karnofsky Performance Status (KPS) is [50]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right frontal periventricular and subcortical white matter, right anterior parietal white matter, right white matter, corpus callosum, anterior limb of the internal capsule, right caudate, bilateral thalami, pons, midbrain, right occipital and parietal white matter extending to the vertex].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cingulate gyrus], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Probable], occurring at [medial and deep margins of the resection cavity in the left posterior frontal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe, extending along the lateral ventricle towards the parietal lobe and superiorly to the left prefrontal cortex], and is characterized as [Glioblastoma (astrocytoma WHO grade IV)]. The tumor measures [4.4 x 3.2 x 2.4 cm in the left anterior temporal lobe and 2.6 x 3.3 x 1.7 cm in the left prefrontal cortex], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe and inferior region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right precentral gyrus and suprasylvian region], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [51 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Probable], occurring at [right lateral precentral gyrus resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe, including the hippocampus and middle temporal gyrus], and is characterized as [Glioblastoma, Astrocytoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe, right frontotemporal lobe, right insular cortex, right superior frontal gyrus, right temporal, and right frontotemporal with underlying resection cavity in the right superior frontal gyrus and right frontotemporal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right superior frontal gyrus medial to the resection cavity, right orbitofrontal gyrus, and subependymal aspect of the right frontal horn].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.52it/s, est. speed input: 9913.7\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior frontal lobe, insula, external capsule, and inferior portions of the pre-and postcentral gyrus]. The tumor is characterized as [Anaplastic astrocytoma]. The tumor measures [6.7 cm AP by 4.7 cm T. by 4.3 cm CC], with a grade of [III]. The WHO grade is [III]. The patient's age is [40], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left corona radiata and corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula, left inferior frontal gyrus, left superior temporal gyrus, left hypothalamus], and is characterized as [Anaplastic Astrocytoma]. The tumor measures [8.4 x 7.4 x 6.4 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [46 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Absent], ATRX status of [Lost], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [posterior, medial, and inferior aspects of the resection cavity involving the left striatum and the left temporal stem].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the medial inferior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Anaplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [65], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Negative], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right ventral medial thalamus and hypothalamus, crossing the midline, with patchy confluent contrast enhancement].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [8.2 x 6.3 x 6.5 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [33 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Not specified]. The patient had a [Craniotomy for tumor resection, Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [paramedian frontal lobe with T2/FLAIR].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe, gyrus rectus], and is characterized as [Anaplastic Astrocytoma]. The tumor measures [2.3 x 2.2 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [good], with tumor progression being [Absent], occurring at [Not applicable].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.98it/s, est. speed input: 9900.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.9 x 6.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporopolar region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not detected], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Encouraging], with tumor progression being [Noted], occurring at [the right temporal stem and posterior aspect of the right insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right anterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.1 x 2.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [Right medial uncus and parahippocampal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [medial right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.6 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [78 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [posterior right parahippocampal gyrus and right amygdala].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right lateral temporal lobe, predominantly involving the superior and middle temporal gyri], and is characterized as [Glioblastoma]. The tumor measures [6.5 x 5.1 x 5.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [73 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right temporal and insular white matter, centrum semi-ovale, right parietal subcortical white matter, and extending into the thalamus, right corticospinal tract, right optic tract and optic chiasm].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.8 x 4.8 x 5.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right frontal FLAIR hyperintensity extending to the precentral gyrus, right insula and external capsule, right superior frontal gyrus, bilateral anterior cingulate cortices, and genu of the corpus callosum on the right].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.58it/s, est. speed input: 9464.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [Left Frontal Lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Left Frontal Lobe extending to the genu of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.4 (AP) x 5 (CC) x 4.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Left frontal craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as part of a clinical trial combining an autologous heat-shock protein vaccine with adjuvant temozolomide.\n",
      "\n",
      "The patient's response to treatment has been [Response not clearly stated], with tumor progression being [Probable], occurring at [peri-cavitary FLAIR hyperintensity, particularly posterior to the resection cavity and in the periventricular white matter of the right frontal horn].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending to the level of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [4.1 x 4.7 x 4.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [83], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable with treatment change v tumor], with tumor progression being [Probable], occurring at [left postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal and temporal lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [31 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right anterior to mid corpus callosum, right anterior frontal lobe, and right caudate head].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left frontal lobe, involving the genu of the corpus callosum and extending into the right frontal and right parietal white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, cingulate gyrus, anterior body of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [IV]. The patient's age is [59], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as part of a clinical trial with autologous heat-shock protein vaccine. The patient's response to treatment has been [good], with tumor progression being [Noted], occurring at [anterior body of the corpus callosum and left frontal centrum semi-ovale].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.60it/s, est. speed input: 9530.1\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right frontal lobe, and is characterized as anaplastic astrocytoma. The tumor measures 9.1 x 6.0 x 7.6 cm, with a grade of III. The WHO grade is III. The patient's age is 27, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant (IDH neg), MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of Positive, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the anterior body and genu of the corpus callosum.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right parietal lobe and right cingulate gyrus, and is characterized as Anaplastic Astrocytoma. The tumor measures not specified, with a grade of III. The WHO grade is III. The patient's age is 57, and Karnofsky Performance Status (KPS) is 70-80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present. PTEN deletion is also noted as Positive.\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ).\n",
      "\n",
      "Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been positive, with tumor progression being Noted, occurring at the left insula and frontal operculum.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right mesial temporal lobe, right lingual gyrus, right lateral occipital cortex, and right amygdala], and is characterized as [Infiltrating Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [74 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present with a ratio of EGFR to CEP7 of 1.19].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right amygdala and tail of hippocampus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [anterior to the resection cavity in the insula and inferior frontal lobe and posterior to the cavity in the hippocampal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior-inferior temporal lobe, insular cortex, right temporal operculum, right temporal stem, and medially into the head and body of the right hippocampus and fibers of the right anterior commissure], and is characterized as [Aplastic Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [43 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right anteromedial temporal lobe, right insula, and right orbitofrontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the medial right temporal lobe, involving the right amygdala and hippocampus, and is characterized as Anaplastic Astrocytoma. The tumor measures 5 cm, with a grade of III. The WHO grade is III. The patient's age is 33 years, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 6000 rads over not specified fractions. Chemotherapy drug was Temozolomide (TMZ).\n",
      "\n",
      "Immunotherapy was Not Used. The patient's response to treatment has been Stable, with tumor progression being Absent, occurring at not specified.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.00it/s, est. speed input: 9969.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior temporal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.3 x 3.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [49 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Absent], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior temporal gyrus including transverse gyrus and underlying white matter], and is characterized as [Glioblastoma]. The tumor measures [3.4 x 1.9 x 2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left posterior insular cortex].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal pole], and is characterized as [Glioblastoma]. The tumor measures [1.9 x 1.4 x 1.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent]. The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [left medial temporal lobe and hippocampus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.6 x 3.5 x 3.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [33], and Karnofsky Performance Status (KPS) is [80-90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior temporal lobe within the superior temporal gyrus], and is characterized as [Glioblastoma]. The tumor measures [2 cm AP x 1.8 cm transverse x 1.9 cm craniocaudal], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [L > R mesial temporal lobe, without enhancement, with linear restricted diffusion, that is concerning for post-ictal changes].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [superior temporal gyrus], and is characterized as [Glioblastoma]. The tumor measures [3.2 cm x 2.7 cm x 4.2 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion [Present] with loss of chromosome 10 [83% of cells].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Absent], occurring at [not applicable].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.87it/s, est. speed input: 9784.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic oligoastrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [39 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [right frontal craniotomy with motor mapping for tumor resection, Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Bilateral frontal lobes], specifically in the [callosal genu, rostrum, and anterior body of the corpus callosum as well as the frontal lobes, right greater than left], and is characterized as [Aplastic oligodendroglioma]. The tumor measures [6.6 x 4.3 x 4.8 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Present], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable disease], with tumor progression being [Noted], occurring at [the right aspect of the resection cavity and extensive masslike FLAIR hyperintensity extending inferiorly from the rostrum and genu of the corpus callosum into the medial aspect of the left greater than right frontal lobes].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending to the anterior insula and genu of the corpus callosum], and is characterized as [anaplastic oligoastrocytoma, astrocyte-predominant]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [56], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present for 1p deletion only, no deletion of 19q], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [tolerated well with mild fatigue and constipation], with tumor progression being [Noted], occurring at [left frontal lobe resection cavity, left inferior gyrus rectus, and the left putamen].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Anaplastic oligoastrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [70]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified]. The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left frontal and parietal centrum semiovale, genu of the corpus callosum, and right periventricular frontal white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe extending into the posterior insula and periatrial white matter], and is characterized as [Aplastic Oligoastrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [31 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Left Temporal Craniotomy for Tumor Resection with Awake Speech Mapping], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.6 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe, insular lobe, basal ganglia, and extending into the right insular region and internal capsule, crossing corpus callosum], and is characterized as [Aplastic Oligoastrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [77 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [residual T-2 FLAIR tumor in the frontal lobe inferior to the resection cavity and some abnormal T-2 crossing midline].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.59it/s, est. speed input: 9690.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe with involvement of the right frontal lobe, genu of the corpus callosum bilaterally, and extending inferiorly and laterally into the left frontal operculum], and is characterized as [Anaplastic oligodendroglioma]. The tumor measures [5.7 x 6.0 x 6.5 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Absent], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [posterior to the resection cavity, involving the rostrum, genu, and anterior trunk of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, involving the left middle and superior frontal gyri and left frontal deep white matter], and is characterized as [Anaplastic oligodendroglioma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [80 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left superior frontal gyrus, left frontal centrum semiovale and extending into the left aspect of the genu of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Aplastic oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [42 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Left frontal craniotomy for tumor resection, awake speech mapping], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted/Absent/Probable], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior frontal gyrus extending back to the motor strip], and is characterized as [Anaplastic oligodendroglioma]. The tumor measures [7 x 3 x 4 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted/Absent/Probable], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe extending through the temporal stem involve left anterior temporal lobe and across midline to involve the genu and rostrum of the corpus callosum and right frontal lobe as well as bilateral fornices], and is characterized as [Aplastic oligodendroglioma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [43], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Response to therapy with decrease in mass effect and midline shift], with tumor progression being [Probable], occurring at [anterior corpus callosum and right inferior frontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Anaplastic Oligodendroglioma]. The tumor measures [central enhancing component approximately 1 cm], with a grade of [Grade III]. The WHO grade is [III]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Present], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Craniotomy with Awake EEG & Speech Mapping, Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Absent], occurring at [Not applicable].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.53it/s, est. speed input: 9345.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left parietal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior parietal lobule], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [3.5 x 3.2 x 3.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [anterior to the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [77 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left periatrial white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior parietal lobule, including postcentral gyrus and extending into the precentral gyrus], and is characterized as [Glioblastoma (Astrocytoma WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left superior parietal lobule and anterior to the resection bed].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe, specifically the medial left superior parietal lobule and posterior cingulate and precuneal regions], and is characterized as [Glioblastoma (Astrocytoma, WHO Grade IV)]. The tumor measures [not specified], with a grade of [III on initial frozen section, later confirmed as IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [90 at last follow-up].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.40 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] in the form of a [vaccine study targeting EGFR].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the splenium of the corpus callosum and within the left frontal lobe, with new areas of nodular enhancement within the right aspect of the splenium].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left inferior parietal lobule], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [1.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left inferior parietal lobe].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.51it/s, est. speed input: 9258.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Anaplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [65], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Negative], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right ventral medial thalamus and hypothalamus, crossing the midline, with patchy confluent contrast enhancement].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right frontal lobe, and is characterized as anaplastic astrocytoma. The tumor measures 9.1 x 6.0 x 7.6 cm, with a grade of III. The WHO grade is III. The patient's age is 27, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant (IDH neg), MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of Positive, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the anterior body and genu of the corpus callosum.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Frontal/Thalamic and Parietal Lobe, and is characterized as Aplastic Astrocytoma. The tumor measures not specified, with a grade of III. The WHO grade is III. The patient's age is 65, and Karnofsky Performance Status (KPS) is 60. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Surgery Type, biopsies only, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been mixed, with tumor progression being Noted, occurring at Right thalamus and new focal zones of signal abnormality involving the periventricular white matter adjacent to the right frontal horn.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [Retained], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe, motor cortex, and straddling the corpus callosum], and is characterized as [Aplastic Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [34 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [significant interval response to treatment manifested by markedly decreased masslike FLAIR abnormality], with tumor progression being [Probable], occurring at [precentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right thalamus extending to the right midbrain and pons], and is characterized as [Anaplastic Astrocytoma]. The tumor measures [6.3 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [39], and Karnofsky Performance Status (KPS) is [60-80, as it varies across the notes].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Right corol hole biopsy with navigation], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [improved clinically with improvement of mood and psychological functioning], with tumor progression being [Noted], occurring at [the splenium of the corpus callosum and right thalamus].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.94it/s, est. speed input: 9730.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [41 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior to the right frontal resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right suprasylvian posterior frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.9 x 2.7 x 2.2 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [78 years], and Karnofsky Performance Status (KPS) is [30-40].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Surgery Type, Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [53.35 Gy] over [25] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal, parietal, and temporal lobes].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.3 x 3.3 x 3.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right frontal, parietal and temporal lobes as well as the right thalamus and subcortical white matter].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [1.7 x 1.8 x 1.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [49 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal operculum and insular cortex].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.07it/s, est. speed input: 10058.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe and left parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the anterior margin of the resection cavity with a 12 x 7 mm residual nodule of enhancing tissue and adjacent tissue demonstrating diffusion restriction].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [the deep margin of the resection cavity extending to the left atrial ventricular surface as well as the inferior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe], and is characterized as [Glioblastoma (WHO grade IV astrocytoma)]. The tumor measures [3.4 x 4.0 x 3.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left occipital lobe with increased size and mass effect on the left lateral ventricle occipital horn and atrium].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal and occipital lobes], and is characterized as [Glioblastoma multiforme, with possible oligo component]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present but rare cells positive for EGFR Amplification, Negative for EGFR Amplification in the majority of tumor cells, Overall, relative copy gain of EGFR].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior aspect of the parietal lobe, margin of the anterior horn of the left lateral ventricle, splenium of corpus callosum, left hippocampus, and along the ependymal surface of the fourth ventricle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal-occipital lobe], and is characterized as [Glioblastoma multiforme (Astrocytoma, WHO grade IV)]. The tumor measures [4.2 cm in transaxial dimensions and 4.4 cm in craniocaudal extent], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [left occipital lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe], and is characterized as [Glioblastoma WHO grade-4]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left occipital lobe with nodular enhancement within the surgical bed extending to the ependymal surface of the left occipital horn, associated increase in perifocal left occipital and parietal edema with mass effect on the left lateral ventricular system].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.44it/s, est. speed input: 9662.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [approximately 3.8 x 2.6 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [60-80, as it varied over the course of treatment].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4005 cGy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used, but discontinued after progression].\n",
      "\n",
      "The patient's response to treatment has been [Stable, treatment effects], with tumor progression being [Noted], occurring at [right posterior frontal resection cavity and surrounding areas].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [41 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior to the right frontal resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal operculum], and is characterized as [Glioblastoma]. The tumor measures [1.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [posterior margins of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [posterior right frontal operculum], and is characterized as [Glioblastoma]. The tumor measures [3.9 x 3.2 x 3.2 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [74 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.93it/s, est. speed input: 9719.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior cingulate and postcentral gyri], and is characterized as [Glioblastoma]. The tumor measures [1.9 x 2.9 x 2.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left superior frontal gyrus, paracentral lobule and cingulate gyrus with scattered foci of FLAIR hyperintensity involving the right frontal periventricular white matter with possible cavitation and suggestion of cortical involvement of the right inferior frontal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial aspect of the left precentral gyrus], and is characterized as [Glioblastoma]. The tumor measures [3.6 x 3.3 x 2.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left pulvinar and left periatrial region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior temporal gyrus including transverse gyrus and underlying white matter], and is characterized as [Glioblastoma]. The tumor measures [3.4 x 1.9 x 2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left posterior insular cortex].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left middle frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.3 x 4.2 x 4.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [37 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Not specified], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior temporal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.3 x 3.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [49 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Absent], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left precentral gyrus extending to the cingulate gyrus medially, the posterior aspect of the superior frontal gyrus anteriorly, and the supramarginal gyrus posteriorly], and is characterized as [Glioblastoma]. The tumor measures [3.9 x 3.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [49 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion is [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [inferomedial tumor margin with nodular enhancement measuring 9 x 11 x 10 mm and increased perilesional T2/FLAIR signal abnormality].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.25it/s, est. speed input: 8838.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior frontal lobe, insula, external capsule, and inferior portions of the pre-and postcentral gyrus]. The tumor is characterized as [Anaplastic astrocytoma]. The tumor measures [6.7 cm AP by 4.7 cm T. by 4.3 cm CC], with a grade of [III]. The WHO grade is [III]. The patient's age is [40], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left corona radiata and corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right frontal lobe, and is characterized as anaplastic astrocytoma. The tumor measures 9.1 x 6.0 x 7.6 cm, with a grade of III. The WHO grade is III. The patient's age is 27, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant (IDH neg), MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of Positive, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the anterior body and genu of the corpus callosum.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left middle frontal gyrus], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [36 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Loss], TERT promoter mutation [not specified], and EGFR amplification [not specified]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left middle frontal gyrus with residual nonenhancing tumor extending into the body of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right parietal lobe and right cingulate gyrus, and is characterized as Anaplastic Astrocytoma. The tumor measures not specified, with a grade of III. The WHO grade is III. The patient's age is 57, and Karnofsky Performance Status (KPS) is 70-80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present. PTEN deletion is also noted as Positive.\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ).\n",
      "\n",
      "Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been positive, with tumor progression being Noted, occurring at the left insula and frontal operculum.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [8.2 x 6.3 x 6.5 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [33 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Not specified]. The patient had a [Craniotomy for tumor resection, Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [paramedian frontal lobe with T2/FLAIR].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Left hemisphere, specifically in the middle frontal gyrus, and is characterized as Anaplastic Astrocytoma. The tumor measures 3.0 x 2.7 x 2.6 cm, with a grade of III. The WHO grade is III. The patient's age is 37, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Mutant, MGMT promoter methylation status of Not Specified, 1p/19q co-deletion Absent, ATRX status of Not Specified, TERT promoter mutation Absent, and EGFR amplification Absent. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over Not Specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Stable, with tumor progression being Absent, occurring at Not Specified.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.94it/s, est. speed input: 9644.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not detected], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Encouraging], with tumor progression being [Noted], occurring at [the right temporal stem and posterior aspect of the right insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe, right insula, right thalamus, and right corticospinal tract].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.9 x 6.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporopolar region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.9 x 4.6 x 4.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [75], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left medial temporal lobe concerning for nonenhancing glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right anterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.1 x 2.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [Right medial uncus and parahippocampal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right temporal operculum], and is characterized as [Glioblastoma]. The tumor measures [up to 5.9 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not detected], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [anterior lateral aspect of the resection cavity and right mesial temporal lobe].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.11it/s, est. speed input: 10047.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right anterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.1 x 2.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [Right medial uncus and parahippocampal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not detected], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Encouraging], with tumor progression being [Noted], occurring at [the right temporal stem and posterior aspect of the right insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.9 x 6.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporopolar region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior temporal lobe including portions of the hippocampus], and is characterized as [Glioblastoma]. The tumor measures [2.3 x 3.6 x 3.9 cm (lat x AP x CC)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [51 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma (GBM)]. The tumor measures [7.8 x 5.6 x 4.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [posterior medial right temporal lobe, involving the posterior body and tail of the hippocampus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right anterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.6 x 3.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [right temporal operculum, middle temporal gyrus, inferior temporal gyrus, and hippocampal head].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.01it/s, est. speed input: 10021.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left middle frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.3 x 4.2 x 4.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [37 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Not specified], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [3.4 x 3.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [73], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left frontal lobe with surrounding vasogenic edema extending into the insula and into the left frontal and parietal lobes as well as into the external capsule and posterior limb of the internal capsule].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma, -type]. The tumor measures [3.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left middle frontal gyrus, in the surgical cavity, with extension inferiorly to the left lateral ventricle level with associated areas of necrosis consistent with tumor progression].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [60-70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the right medial frontal gyrus and gyrus rectus along the posterior and inferior resection margins].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.6 x 4.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [43 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [recovering well], with tumor progression being [Noted], occurring at [the posterior aspect of the resection cavity as well as crossing the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [inferior frontal gyrus], and is characterized as [Glioblastoma multiforme]. The tumor measures [3.2 x 2.7 x 3.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [75], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [tolerated initial chemoradiation well], with tumor progression being [Noted], occurring at [posterior and inferior margins of the resection cavity].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.94it/s, est. speed input: 9991.1\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [posterior left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.6 x 6.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable post-op], with tumor progression being [Noted], occurring at [left inferior frontal cortex and thalamus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.4 x 3.9 x 4.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [77 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40 Gy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [medial left frontal lobe near the left anterior falx].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [Left Frontal Lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Left Frontal Lobe extending to the genu of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.6 x 4.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [43 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [recovering well], with tumor progression being [Noted], occurring at [the posterior aspect of the resection cavity as well as crossing the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [wildtype], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not amplified in majority of cells].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Mixed response to therapy], with tumor progression being [Noted], occurring at [posterior left frontal lobe with surrounding FLAIR].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.2 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [non-informative], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not clearly stated], with tumor progression being [Probable], occurring at [left frontal mass].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.00it/s, est. speed input: 9813.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.1 x 2.6 x 2.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Present], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [anterior aspect of resection cavity and right occipital lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.9 x 2.5 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right parieto-occipital lobes, right frontal lobe, and right cerebellum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietotemporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right temporal lobe extending superiorly along the atrium of the right lateral ventricle, right interl and exterl capsules, right thalamus, midbrain, hypothalamus, and cerebral peduncle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.6 x 3.5 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present with a relative copy gain].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used in the form of an investigational vaccine as part of the ACT IV CDX trial].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Probable], occurring at [right posterior parietal white matter and nodular area of enhancement in right postcentral gyrus adjacent to the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the parieto-occipital lobe, and is characterized as Glioblastoma. The tumor measures 6.1 x 4.5 x 5.2 cm, with a grade of IV. The WHO grade is IV. The patient's age is 34, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion Not Specified, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Absent.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the resection cavity with increased peripheral enhancement and enlargement of the right parietal resection cavity, with increased T2/FLAIR signal abnormality compared to MRI from previous dates.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right parieto-occipital region], and is characterized as [Glioblastoma]. The tumor measures [4.8cm x 4.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Probable], occurring at [anterior to the resection cavity, immediately posterior to the posterior aspect of the sylvian fissure with slight increase in T2/FLAIR hyperintensity].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.42it/s, est. speed input: 9261.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the parieto-occipital lobe, and is characterized as Glioblastoma. The tumor measures 6.1 x 4.5 x 5.2 cm, with a grade of IV. The WHO grade is IV. The patient's age is 34, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion Not Specified, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Absent.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the resection cavity with increased peripheral enhancement and enlargement of the right parietal resection cavity, with increased T2/FLAIR signal abnormality compared to MRI from previous dates.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal occipital region], and is characterized as [Glioblastoma, IDH-wildtype]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90 initially, later 80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Near Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [posterior superior aspect of the resection cavity as well as slightly enhancing nodule just superior to this, and along the resection cavity].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [the deep margin of the resection cavity extending to the left atrial ventricular surface as well as the inferior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left parieto-occipital region, and is characterized as Glioblastoma. The tumor measures approximately 4.8 x 3.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 50 years, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 wildtype), MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification Present. PTEN deletion is also noted.\n",
      "\n",
      "The patient had a near Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been mixed, with tumor progression being Noted, occurring at the left periventricular region, splenium, and left parietal lobe.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal and occipital lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Right parietal craniotomy for gross total resection of glioblastoma under image guidance], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as the patient was enrolled in a clinical trial of heat shock protein vaccine.\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right inferior parietal lobule, and the inferior right post and pre-central gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the occipital lobe, and is characterized as Glioblastoma. The tumor measures up to 2.5 cm, with a grade of IV. The WHO grade is IV. The patient's age is 57 years, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (negative with the antibodies against IDH-1 R132H mutant protein), MGMT promoter methylation status of Not specified, 1p/19q co-deletion Not specified, ATRX status of Not specified, TERT promoter mutation Not specified, and EGFR amplification Not specified.\n",
      "\n",
      "The patient had a Craniotomy for Tumor Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been Not specified, with tumor progression being Noted, occurring at the inferior and inferoposterior aspects of the right occipital resection cavity.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.57it/s, est. speed input: 9428.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left parahippocampal gyrus and hippocampus, left temporal stem and white matter, and left frontal lobe white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left medial temporal lobe involving the left amygdala, hippocampal head and body, and parahippocampal gyrus with extension of disease to involve the right substantia innomita, bilateral hypothalamus, and optic chiasm], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left mesial temporal lobe with extension into the left cerebral peduncle and thalamus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe, left white matter, left inferior frontal lobe, left amygdala, left hippocampal head, and left hippocampal body], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [38 years], and Karnofsky Performance Status (KPS) is [70-80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left anterior temporal resection cavity, involving superiormiddle temporal gyrus, insula, hippocampus, and temporal stem].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior temporal gyrus including transverse gyrus and underlying white matter], and is characterized as [Glioblastoma]. The tumor measures [3.4 x 1.9 x 2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left posterior insular cortex].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior temporal lobe within the superior temporal gyrus], and is characterized as [Glioblastoma]. The tumor measures [2 cm AP x 1.8 cm transverse x 1.9 cm craniocaudal], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [L > R mesial temporal lobe, without enhancement, with linear restricted diffusion, that is concerning for post-ictal changes].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left mesial temporal lobe, primarily involving cortex and subcortical white matter of the left parahippocampal gyrus ventrally], and is characterized as [Glioblastoma]. The tumor measures [up to 4.0 x 2.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left anterior temporal lobe, uncus, and amygdala].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.54it/s, est. speed input: 9623.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the temporoparietal region, and is characterized as Glioblastoma. The tumor measures 7 x 5 x 4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 65, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Near Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Stable, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporoparietal area], and is characterized as [Glioblastoma]. The tumor measures [4.8 x 5.2 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right temporal lobe and corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Temporal Lobe, and is characterized as Glioblastoma. The tumor measures 6.3 x 4.8 cm, with a grade of IV. The WHO grade is IV. The patient's age is 54, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Not Specified, 1p/19q co-deletion Absent, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Present. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over Not Specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Used. The patient's response to treatment has been Stable, with tumor progression being Absent, occurring at Not Specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right temporal lobe, and is characterized as Glioblastoma. The tumor measures 5 x 8 x 4.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 68, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Probable, occurring at the superior and medial margins of the resection cavity and increased extent of FLAIR hyperintensity.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [R temporoparietal], and is characterized as [Glioblastoma]. The tumor measures [4.0 x 5.0 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [90 initially, later 60]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [the right parietal lobe, involving the posterior right temporal lobe, right parietal lobe, and posterior right frontal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the temporoparietal region, and is characterized as Glioblastoma. The tumor measures 4.0 x 3.7 x 4.0 cm, with a grade of IV. The WHO grade is IV. The patient's age is 63, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the right temporal and right parietal lobes.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.12it/s, est. speed input: 9708.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cingulate gyrus], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Probable], occurring at [medial and deep margins of the resection cavity in the left posterior frontal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma (Astrocytoma WHO grade IV)]. The tumor measures [5.3x5.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Not specified], occurring at [Not specified].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the anterior temporal lobe, and is characterized as Glioblastoma (Astrocytoma, WHO grade IV). The tumor measures 2.1 x 0.9 x 1.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 66, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the ventral margins of the resection cavity.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe, extending along the lateral ventricle towards the parietal lobe and superiorly to the left prefrontal cortex], and is characterized as [Glioblastoma (astrocytoma WHO grade IV)]. The tumor measures [4.4 x 3.2 x 2.4 cm in the left anterior temporal lobe and 2.6 x 3.3 x 1.7 cm in the left prefrontal cortex], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe and inferior region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [80 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [unable to be determined], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN status is [deleted].\n",
      "\n",
      "The patient had a [right frontal craniotomy for resection of cystic glioblastoma with intraoperative motor mapping], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the right internal capsule and new nodular ependymal enhancement at the right frontal horn].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [posterior left frontal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [2.5 x 2 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Negative for EGFR Amplification].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left subcortical motor tract].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.90it/s, est. speed input: 9935.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [pons, midbrain, right middle cerebellar peduncle, right cerebral peduncle, and right brachium pontis], and is characterized as [Astrocytoma, specifically anaplastic astrocytoma]. The tumor measures [approximately 2.5 x 3.1 x 2.3 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [4 years], and Karnofsky Performance Status (KPS) is [100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Bevacizumab (Avastin)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [positive, with significant reduction in the extent of T2 FLAIR signal abnormality], with tumor progression being [Noted], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [brainstem, upper medulla extending into the lower pons], and is characterized as [Astrocytoma]. The tumor measures [1.2 (AP) x 1.5 (transverse) x 2.6 (CC) cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [12 years], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Stereotactic brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [54 Gy] over [30] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Improvement in ambulation, left-sided weakness remained stable], with tumor progression being [Noted], occurring at [right cranial pons extending diffusely throughout the mid pons and into the medulla with right greater than left exophytic expansion ventrally].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [pons and medullary pyramid], and is characterized as [High grade infiltrative astrocytoma, WHO grade III]. The tumor measures [4.1 cm transverse x 2.5 cm AP x 3.7 cm craniocaudal], with a grade of [III]. The WHO grade is [III]. The patient's age is [15 years], and Karnofsky Performance Status (KPS) is [Not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Stereotactic brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [30.6 Gy] over [17] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Improvement], with tumor progression being [Noted], occurring at [periventricular and subependymal regions along the bilateral lateral ventricles, anterior recess of third ventricle/hypothalamus, and fourth ventricle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [Retained], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cerebellar hemisphere, left pons, brachium pontis, and left cerebral peduncle], and is characterized as [Infiltrating astrocytoma, suspect high-grade astrocytoma]. The tumor measures [2.3 x 1.7-cm in greatest transaxial dimension], with a grade of [suspected high-grade, but specimen too small for accurate grading]. The WHO grade is [not specified]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Left suboccipital burr hole for tumor biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left pons, brachium pontis, and left cerebellar hemisphere].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [pons and extending into the right cerebellar hemisphere], and is characterized as [Astrocytoma]. The tumor measures [3.1 x 3.6 x 3.2 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [8 years], and Karnofsky Performance Status (KPS) is [70-100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Not noted/Absent], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.56it/s, est. speed input: 9749.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the temporal lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 69, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of Positive, TERT promoter mutation not specified, and EGFR amplification Present.\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 6000 cGy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been stable, with tumor progression being Noted, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Temporal Lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 55, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 -type), MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been tolerating well, with tumor progression being Probable, occurring at the resection cavity extending superiorly into the right parietal lobe and right posterior frontal lobes as well as medially into the right lateral aspect of the thalamus.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right temporal lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of not specified. The WHO grade is IV. The patient's age is 50, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of pending, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been concerning for post-radiation versus tumor progression, with tumor progression being Probable, occurring at Right temporal resection cavity.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right temporal region, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of not specified. The WHO grade is IV. The patient's age is 66, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of Negative, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the deep superior margin of the surgical cavity at the medial temporal lobe and insula.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Temporal Lobe, and is characterized as Glioblastoma. The tumor measures 6.3 x 4.8 cm, with a grade of IV. The WHO grade is IV. The patient's age is 54, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Not Specified, 1p/19q co-deletion Absent, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Present. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over Not Specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Used. The patient's response to treatment has been Stable, with tumor progression being Absent, occurring at Not Specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the temporal lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 51, and Karnofsky Performance Status (KPS) is initially 90, later 70, and then 60.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (negative for IDH mutation by IHC), MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified (patient wants to be screened for EGFR viii).\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been variable, with tumor progression being Noted, occurring at the right cerebral peduncle extending into the right pons, midbrain, and associated with a ventral region of reduced diffusion.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.26it/s, est. speed input: 9719.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the temporal lobe, and is characterized as Glioblastoma. The tumor measures 4.2 x 2.2 x 5.0 cm, with a grade of IV. The WHO grade is IV. The patient's age is 77, and Karnofsky Performance Status (KPS) is not specified.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (negative for IDH-1 R132H mutant protein), MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present (positive for EGFR Amplification with an average number of EGFR signals per cell of 24.4).\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the left temporal lobe with residual tumor and enhancing left ependymal nodule persisting post-surgery.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the posterior left middle and inferior temporal lobes, and is characterized as Glioblastoma. The tumor measures 5.7 x 2.9 x 4.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 67, and Karnofsky Performance Status (KPS) is not specified.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (negative for mutant protein), MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of Positive (retention of expression), TERT promoter mutation not specified, and EGFR amplification Absent (Negative for EGFR Amplification).\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the inferior margin of the resection site and enhancement along the dura of the adjacent left tentorium.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe and left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [79 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left temporal lobe and left frontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left medial frontal area and left cingulate gyrus], and is characterized as [Glioblastoma]. The tumor measures [up to 2 cm in greatest transverse dimension], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [75 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Absent], occurring at [Not specified].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right anterior temporal lobe, insula, and temporal stem, and is characterized as Glioblastoma. The tumor measures 6.0 x 4.7 x 6.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 76, and Karnofsky Performance Status (KPS) is not specified.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (negative for the IDH-1 mutant protein), MGMT promoter methylation status of Methylated (methylation index = 9), 1p/19q co-deletion not specified, ATRX status of Positive (retention of ATRX), TERT promoter mutation not specified, and EGFR amplification Present (Positive for EGFR Amplification with an average number of EGFR signals per cell: 23 and a ratio of EGFR to CEP7: 9.2).\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was not specified in the notes provided. Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the right ventricular margin (as enhancing tissue remains, extending into the right ventricular margin post-surgery).\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Left hemisphere, specifically in the posteroinferior temporal lobe, and is characterized as Glioblastoma multiforme. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 67, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (negative with the antibodies against IDH-1 (R132H) mutant protein), MGMT promoter methylation status of Unmethylated (MGMT methylation assay was \"not detected\"), 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present (Positive for EGFR Amplification with an average number of EGFR signals per cell: 23.72 and a ratio of EGFR to CEP7 of 10.1).\n",
      "\n",
      "The patient had a Surgery Type, Gross Total Resection (GTR) of the enhancing component, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Used (patient is undergoing treatment with vaccine/placebo).\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the surgical site and the anterior left temporal satellite enhancing nodule.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.48it/s, est. speed input: 9242.4\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal, parietal, and insular cortex], and is characterized as [Anaplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion was also noted as [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left anterior and medial temporal lobe and insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior frontal lobe, insula, external capsule, and inferior portions of the pre-and postcentral gyrus]. The tumor is characterized as [Anaplastic astrocytoma]. The tumor measures [6.7 cm AP by 4.7 cm T. by 4.3 cm CC], with a grade of [III]. The WHO grade is [III]. The patient's age is [40], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left corona radiata and corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [pons and medullary pyramid], and is characterized as [High grade infiltrative astrocytoma, WHO grade III]. The tumor measures [4.1 cm transverse x 2.5 cm AP x 3.7 cm craniocaudal], with a grade of [III]. The WHO grade is [III]. The patient's age is [15 years], and Karnofsky Performance Status (KPS) is [Not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Stereotactic brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [30.6 Gy] over [17] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Improvement], with tumor progression being [Noted], occurring at [periventricular and subependymal regions along the bilateral lateral ventricles, anterior recess of third ventricle/hypothalamus, and fourth ventricle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right mesial temporal lobe, right lingual gyrus, right lateral occipital cortex, and right amygdala], and is characterized as [Infiltrating Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [74 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present with a ratio of EGFR to CEP7 of 1.19].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right amygdala and tail of hippocampus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe, amygdala, hippocampus, fornix, hippocampal commissure, column, anterior commissure, and anterior parietal lobe], and is characterized as [Astrocytoma]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [III]. The patient's age is [50 years], and Karnofsky Performance Status (KPS) is [50].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Negative], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior and posterior to the left temporal surgical cavity and left prepontine cistern].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left putamen and globus pallidus, insular cortex, extending across the left temporal stem into the left mesial and anterior temporal lobe, and second dominant region of masslike FLAIR signal in the left frontal lobe crossing the callosal genu to the right frontal lobe white matter], and is characterized as [High grade astrocytoma, consistent with Anaplastic Astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [54], and Karnofsky Performance Status (KPS) is [60%].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [bifrontal, corpus callosum, left insular temporal and basal ganglia regions].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.38it/s, est. speed input: 9534.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal and occipital lobes], and is characterized as [Glioblastoma multiforme, with possible oligo component]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present but rare cells positive for EGFR Amplification, Negative for EGFR Amplification in the majority of tumor cells, Overall, relative copy gain of EGFR].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior aspect of the parietal lobe, margin of the anterior horn of the left lateral ventricle, splenium of corpus callosum, left hippocampus, and along the ependymal surface of the fourth ventricle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial left posterior frontal lobe, medial left parietal lobe, medial left occipital lobe, left anterior cingulate gyrus, and right anterior inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [80-90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present/Absent - with a subpopulation of EGFR amplified cells noted, overall tumor negative for EGFR amplification]. The patient had a [Stereotactic brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left parietal, right parietal-occipital, and left posteromedial temporal white matter].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left superior parietal lobule, extending into the superior parietal lobule, post central gyrus, the left parietal and frontal periventricular white matter, periatrial white matter, posterior limb of the internal capsule and along the left temporal horn], and is characterized as [Glioblastoma]. The tumor measures [2.4 x 1.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [71], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used]. The patient's response to treatment has been [stable with no evidence of progression], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [insular, parietal, and temporal lobes], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for open biopsy; possible microdissection/neuro navigation (Craniotomy)], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and parietal and temporal lobes, as well as left hemisphere deep white matter, cuneus, and left thalamus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [L parietal, multifocal], and is characterized as [Glioblastoma, IDH WT, methylated]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [IV]. The patient's age is [78 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Resection by Dr. (name not specified), pathology=GBM, IDH WT, methylated], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used - BMS 548 clinical trial, placebo].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior left cingulate gyrus, splenium of the corpus callosum, left posterior corpus callosum, and adjacent to the atrium of left lateral ventricle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [superior and inferior parietal lobes, extending slightly into the posterior left frontal lobe, cingulum, left periventricular white matter, atria of the left lateral ventricle, and slightly into the splenium of the corpus callosum], and is characterized as [Glioblastoma multiforme with an oligodendroglial component]. The tumor measures [2.1 cm nodule with additional nodules and spicules], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [craniotomy with motor mapping for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [stable without evidence of progression], with tumor progression being [Absent], occurring at [not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.19it/s, est. speed input: 9639.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe, extending inferiorly to involve the temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 3.6 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Not noted/Absent/Probable], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [50], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left superior parietal lobule].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.2 AP x 2.2 TV x 2.6 CC cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)], but the patient developed [angioedema and a rash] leading to discontinuation. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [tolerated well with no definitive new suspicious enhancement on post-gadolinium images], with tumor progression being [Not noted/Absent], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.6 x 3.5 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present with a relative copy gain].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used in the form of an investigational vaccine as part of the ACT IV CDX trial].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Probable], occurring at [right posterior parietal white matter and nodular area of enhancement in right postcentral gyrus adjacent to the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior and inferior parietal lobules], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [74], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left inferior parietal lobe], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [3.9 x 3.4 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [100 initially, later 80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion [Positive].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as part of the ACT clinical trial with adjuvant TMZ and vaccine vs KLH placebo.\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted/Absent/Probable], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.52it/s, est. speed input: 9351.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula and mesial temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [3.2 x 4.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ) - although the patient was unable to tolerate it due to nausea]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and mesial temporal lobe, extending into the left hippocampal body and tail].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cingulate gyrus], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Probable], occurring at [medial and deep margins of the resection cavity in the left posterior frontal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe, extending along the lateral ventricle towards the parietal lobe and superiorly to the left prefrontal cortex], and is characterized as [Glioblastoma (astrocytoma WHO grade IV)]. The tumor measures [4.4 x 3.2 x 2.4 cm in the left anterior temporal lobe and 2.6 x 3.3 x 1.7 cm in the left prefrontal cortex], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe and inferior region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporoparietal lobe involving the left inferior parietal lobule and left temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [38 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Not amplified]. The patient had a [Near Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [5.8 x 4.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [51 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Left temporal craniotomy for removal of tumor; image-guided surgical procedure, microdissection technique, intraoperative neuromonitoring with electrocorticography and awake speech mapping techniques], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Noted], occurring at [the anterior, medial, and superomedial aspects of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left insula and temporal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO Grade IV)]. The tumor measures [7.2 x 5.1 x 5.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, non-progressive disease], with tumor progression being [Noted], occurring at [residual enhancement along the deep margins of the surgical bed, and two persistent satellite lesions in the left external capsule and corona radiata].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.40it/s, est. speed input: 9612.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior cingulate and postcentral gyri], and is characterized as [Glioblastoma]. The tumor measures [1.9 x 2.9 x 2.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left superior frontal gyrus, paracentral lobule and cingulate gyrus with scattered foci of FLAIR hyperintensity involving the right frontal periventricular white matter with possible cavitation and suggestion of cortical involvement of the right inferior frontal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe supplementary motor area], and is characterized as [Glioblastoma]. The tumor measures [6 cm in anterior-posterior dimension, 3 cm medial to lateral], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [34], and Karnofsky Performance Status (KPS) is [60]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left cingulate gyrus and corpus callosum with T-2 FLAIR change in that region as well].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending to the level of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [4.1 x 4.7 x 4.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [83], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable with treatment change v tumor], with tumor progression being [Probable], occurring at [left postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending into the corpus callosum, right frontal white matter, left basal ganglia, left cerebral peduncle, and anterior centrum semiovale and corona radiata], and is characterized as [Glioblastoma]. The tumor measures [3.2 x 3.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left frontal lobe, extending into the corpus callosum and right frontal white matter, and inferiorly involving the posterior limb of the left internal capsule, left cerebral peduncle, and superior portion of the left pons].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [60-70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the right medial frontal gyrus and gyrus rectus along the posterior and inferior resection margins].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe extending to the cortical surface at the top of the cortex and mostly anterior to the remaining motor cortex superiorly, left precentral gyrus, left insula], and is characterized as [Glioblastoma]. The tumor measures [4.3 x 2.5 x 3.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion [Present] (loss of chromosome 10).\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the lateral aspect of the right postcentral gyrus consistent with a second low-grade glial neoplasm].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.45it/s, est. speed input: 9717.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [middle cerebellar peduncle, pons, bilateral midbrain, thalamus, and left globus pallidus], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [6 years], and Karnofsky Performance Status (KPS) is [50].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.40 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [thoracic spine (T6 level)].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cerebellar hemisphere and vermis], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62], and Karnofsky Performance Status (KPS) is [70-80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Response to treatment], with tumor progression being [Probable], occurring at [left cerebellar hemisphere].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the deep lateral aspect of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the genu of the corpus callosum and extending to the subcortical frontal lobe white matter and temporal stem].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the right cerebellar hemisphere and middle cerebellar peduncle extending to the right cerebral peduncle, and is characterized as Glioblastoma. The tumor measures [Size in cm not specified], with a grade of IV. The WHO grade is IV. The patient's age is 25, and Karnofsky Performance Status (KPS) is 60. Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified]. The patient had a [Surgery Type not specified], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Total Number Gy not specified] over [Number not specified] fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was [Not Used]. The patient's response to treatment has been [Response not specified], with tumor progression being Noted, occurring at the right posterior fossa glioblastoma spanning from midbrain to inferior cerebellar peduncle.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.02it/s, est. speed input: 9921.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Anaplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [65], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Negative], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right ventral medial thalamus and hypothalamus, crossing the midline, with patchy confluent contrast enhancement].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior-inferior temporal lobe, insular cortex, right temporal operculum, right temporal stem, and medially into the head and body of the right hippocampus and fibers of the right anterior commissure], and is characterized as [Aplastic Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [43 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right anteromedial temporal lobe, right insula, and right orbitofrontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal, parietal, and insular cortex], and is characterized as [Anaplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion was also noted as [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left anterior and medial temporal lobe and insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula, left inferior frontal gyrus, left superior temporal gyrus, left hypothalamus], and is characterized as [Anaplastic Astrocytoma]. The tumor measures [8.4 x 7.4 x 6.4 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [46 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Absent], ATRX status of [Lost], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [posterior, medial, and inferior aspects of the resection cavity involving the left striatum and the left temporal stem].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [4.3 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [27 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. PTEN deletion testing by FISH was [Negative for PTEN deletion].\n",
      "\n",
      "The patient had a [Right parietal craniotomy, navigation microdissection motor mapping, tumor removal], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [Minimal infiltrative T2 FLAIR hyperintensity at the anterior margin of the resection cavity, adjacent to the atrium of the right lateral ventricle, which may represent a small amount of residual nonenhancing tumor].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right insular cortex, subcortical white matter, deep white matter, right putamen, temporal pole, and hippocampus], and is characterized as [Anaplastic Astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [69], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Suboptimal sample yielded low quality DNA; methylation status not clearly indicated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Persistent T2 hyperintense tissue is noted along the medial aspect of the resection cavity in the region of the insula extending into the right putamen and centrum semiovale].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.44it/s, est. speed input: 9468.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left middle frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.3 x 4.2 x 4.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [37 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Not specified], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.5 x 5.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Left frontal craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [right precentral gyrus with minimal postcentral gyrus involvement].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [60-70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the right medial frontal gyrus and gyrus rectus along the posterior and inferior resection margins].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [posterior left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.6 x 6.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable post-op], with tumor progression being [Noted], occurring at [left inferior frontal cortex and thalamus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma, -type]. The tumor measures [3.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left middle frontal gyrus, in the surgical cavity, with extension inferiorly to the left lateral ventricle level with associated areas of necrosis consistent with tumor progression].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, specifically the left precentral gyrus extending to the left frontal operculum], and is characterized as [Glioblastoma]. The tumor measures [2.1 x 2.4 x 2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Absent], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.99it/s, est. speed input: 9969.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, involving the left middle and superior frontal gyri and left frontal deep white matter], and is characterized as [Anaplastic oligodendroglioma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [80 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left superior frontal gyrus, left frontal centrum semiovale and extending into the left aspect of the genu of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending to the anterior insula and genu of the corpus callosum], and is characterized as [anaplastic oligoastrocytoma, astrocyte-predominant]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [56], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present for 1p deletion only, no deletion of 19q], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [tolerated well with mild fatigue and constipation], with tumor progression being [Noted], occurring at [left frontal lobe resection cavity, left inferior gyrus rectus, and the left putamen].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [temporal-occipital lobe], and is characterized as [Grade III astrocytoma, behaves more like malignant glioblastoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [73 years], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [anterior, medial, and inferior aspects of resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial left temporal lobe, specifically the inferior temporal gyrus], and is characterized as [Anaplastic astrocytoma, WHO grade III; early form of glioblastoma, WHO grade IV with incipient microvascular proliferation]. The tumor measures [3.4 x 2.0 x 2.0 cm], with a grade of [III/IV]. The WHO grade is [IV]. The patient's age is [64], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Resolution of the enhancement surrounding the surgical cavity comparing with the prior brain MR, No evidence of tumor progression], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior temporal lobe], and is characterized as [Anaplastic astrocytoma, WHO grade III]. The tumor measures [1.2 x 1.0 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [39], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Left temporal craniotomy for microsurgical resection of glioma with intraoperative awake speech and motor mapping and brain lab image guidance], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [clinically and radiographically stable], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [glioma with histologic features of anaplastic oligoastrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior aspect of the insula, white matter, putamen, and uncus].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.51it/s, est. speed input: 9487.1\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe, extending inferiorly to involve the temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 3.6 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Not noted/Absent/Probable], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left parietal lobe, and is characterized as Glioblastoma. The tumor measures 1.5 cm, with a grade of IV. The WHO grade is IV. The patient's age is 60, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 immunohistochemistry is negative), MGMT promoter methylation status of Unmethylated (Suboptimal sample yielded low quality DNA), 1p/19q co-deletion Absent (not specified), ATRX status of Positive (not specified), TERT promoter mutation Absent (not specified), and EGFR amplification Present (Positive for EGFR Amplification).\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 6 weeks. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the left superior parietal lobule and posterior aspect of the left superior temporal gyrus.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [50], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left superior parietal lobule].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [insular, parietal, and temporal lobes], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for open biopsy; possible microdissection/neuro navigation (Craniotomy)], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and parietal and temporal lobes, as well as left hemisphere deep white matter, cuneus, and left thalamus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe extending into the posterosuperior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [7.2 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [70]. Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified]. The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection] not clearly specified, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4,250 cGy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Improvement in language function and strength], with tumor progression being [Noted], occurring at [left parietal area with compression of the occipital horn of the left ventricle].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left inferior parietal lobe that extends to the superior temporal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [80 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Biopsy without head navigation (Craniotomy)], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Not noted/Absent/Probable], occurring at [Not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.21it/s, est. speed input: 8739.1\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporoparietal lobe involving the left inferior parietal lobule and left temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [38 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Not amplified]. The patient had a [Near Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cingulate gyrus], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Probable], occurring at [medial and deep margins of the resection cavity in the left posterior frontal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [77 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left periatrial white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left parietal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe], and is characterized as [Glioblastoma, Astrocytoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [76], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Probable], occurring at [left temporal fissure].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left frontotemporal lobe], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left temporoparietal lobes].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.07it/s, est. speed input: 10062.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left thalamus], and is characterized as [Glioblastoma]. The tumor measures [5 x 6 x 5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [70%].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [improved], with tumor progression being [Noted], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left thalamus extending into the left midbrain and third ventricle], and is characterized as [Glioblastoma]. The tumor measures [4.0 x 2.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [mixed response with decreased size, enhancement, and surrounding FLAIR abnormality of supratentorial disease centered in the left thalamus with progressed enhancing infratentorial disease in the inferior aspect of the fourth ventricle], with tumor progression being [Noted], occurring at [infratentorial disease in the inferior aspect of the fourth ventricle and extending through the foramen of Magendie with associated increased medullary FLAIR hyperintensity].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left thalamus], and is characterized as [Glioblastoma]. The tumor measures [3.2 x 2.5 x 2.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [75], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left thalamus extending to the posteriosuperior aspect of the left midbrain and tectum plate, posterior portion of the left superior temporal gyrus and occipital lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [thalamus], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as the patient was on a heat shock protein vaccine trial.\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Probable], occurring at [the splenium, and right dorsomedial thalamus and periatrial white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right thalamus], and is characterized as [Glioblastoma]. The tumor measures [3.7 x 3.4 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [32 years], and Karnofsky Performance Status (KPS) is [60]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Surgery Type, Biopsy only], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, non-progressive disease], with tumor progression being [Noted], occurring at [right thalamus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left thalamus and involving the left periventricular white matter, extending into the body of the corpus callosum and left centrum semiovale], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [4.7 x 3.4 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [24 years], and Karnofsky Performance Status (KPS) is [90 initially, later deteriorating].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30 fractions initially planned, but changed to a hypofractionated regimen due to aggressive tumor nature]. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [poor], with tumor progression being [Noted], occurring at [left thalamus with worsening entrapment of the temporal horn of the left lateral ventricle and worsening right lateral ventricular enlargement, worsening midline shift, and worsening left-sided uncal herniation resulting in increased effacement of the bilateral paramesencephalic cisterns, and left greater than right mass effect on the midbrain].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.41it/s, est. speed input: 9586.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right cingulate gyrus extending along the lateral genu of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [2.1 cm (transverse) x 3.1 cm (AP) x 2.4 cm (CC)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe, with surrounding edema-like FLAIR, consistent with high-grade glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right cingulate gyrus and corpus callosum], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [2.2 cm TV x 1 cm AP x 1.6 cm SI], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [2 years], and Karnofsky Performance Status (KPS) is [100: Fully active].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)] and Vorinostat. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left callosal body at the resection margin].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior corpus callosum, extending into the right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [Size in cm not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65], and Karnofsky Performance Status (KPS) is [90 initially, but not specified after treatment].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Total Number Gy not specified] over [Number not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [corpus callosum and extending into the right frontal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe, extending into the genu of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [90 initially, later 60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Suboptimal sample yielded low quality DNA, so status is not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used - the patient was on a vaccine trial].\n",
      "\n",
      "The patient's response to treatment has been [initially stable, later with signs of progression], with tumor progression being [Probable], occurring at [right caudate nucleus and left genu of corpus callosum with new infiltrative disease along the septum pellucidum and left column of fornix].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior frontal gyrus, extending into the anterior body of the corpus callosum and caudate head], and is characterized as [Glioblastoma]. The tumor measures [2.4 x 2.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe and extending into the anterior body of the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [body of the right lateral ventricle and corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 5.0 x 2.9 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [53 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Right frontal burr hole for tumor biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4600 cGy in 23 daily sequential fractions via 6 MV photons prescribed to the 95% isodose line, followed by a boost for an additional 1400 cGy in 7 daily sequential fractions via 6 MV photons prescribed to the 96% isodose line]. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [good response], with tumor progression being [Absent], occurring at [not specified due to absence of progression].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.40it/s, est. speed input: 9572.1\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe], and is characterized as [Glioblastoma, Astrocytoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [76], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Probable], occurring at [left temporal fissure].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporoparietal lobe involving the left inferior parietal lobule and left temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [38 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Not amplified]. The patient had a [Near Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [4.5 cm AP x 2.5 cm TV x 2.5 cm SI], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Left temporal craniotomy for tumor resection with awake speech mapping, Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Probable], occurring at [left temporal lobe resection cavity with a thicker enhancing rim].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior temporal lobe], and is characterized as [Glioblastoma, (Astrocytoma WHO Grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Absent], occurring at [not applicable].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula and mesial temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [3.2 x 4.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ) - although the patient was unable to tolerate it due to nausea]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and mesial temporal lobe, extending into the left hippocampal body and tail].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [72 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Absent], occurring at [not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.90it/s, est. speed input: 9897.7\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior temporal lobe], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the anteromedial resection margin and increasing white matter FLAIR signal abnormality in the left temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma WHO grade-4]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [70-80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [Present/Absent not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left temporal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left parahippocampal gyrus and hippocampus, left temporal stem and white matter, and left frontal lobe white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma, WHO Grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left temporal lobe and C5-C7 levels of the spinal cord].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] but discontinued due to transaminitis.\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left posterior temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [medial left temporal lobe, including the residual uncus and hippocampus, and an area of expanded left insular cortex].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.01it/s, est. speed input: 9899.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe and body of the right hippocampus], and is characterized as [Aplastic ganglioglioma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [15 years], and Karnofsky Performance Status (KPS) is [90-100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified]. The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [5940 cGy] over [33] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left occipital lobe along the anterior-inferior margin of the cavity, extending to the ependymal margin of the left occipital horn, and FLAIR signal abnormality extending from the lateral margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right frontal lobe, insula, and basal ganglia, and right anterior temporal lobe], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [Right frontotemporal region with irregular rim enhancing resection cavity and associated edema].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right mesial temporal lobe, right precuneus-cuneus, and lateral aspect of the right parietal lobe], and is characterized as [Ganglioglioma, with features suggesting transformation to a high-grade glioma, possibly glioblastoma with PNET features]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [not specified]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Right parietal craniotomy for open tumor biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right parietal lobe, right precuneus-cuneus, and lateral aspect of the right parietal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [anterior to the resection cavity in the insula and inferior frontal lobe and posterior to the cavity in the hippocampal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right basal ganglia, and is characterized as Glioblastoma, wildtype. The tumor measures not specified, with a grade of not specified. The WHO grade is IV. The patient's age is 71 years, and Karnofsky Performance Status (KPS) is 60. Key molecular markers include an IDH mutation status of Wildtype, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified.\n",
      "\n",
      "The patient had a Biopsy, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 40 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at Right frontal lobe, basal ganglia, thalamus, right cerebral peduncle, right pons, right white matter, temporal stem and into the periventricular white matter of the anterior right temporal lobe, and a second discrete area within the left dentate nucleus.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe and basal ganglia], and is characterized as [Aplastic ganglioglioma, WHO grade III]. The tumor measures [3.3 cm AP x 2.8 cm transverse x 2.4 cm craniocaudal], with a grade of [III]. The WHO grade is [III]. The patient's age is [37 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6500 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] with the administration of [bevacizumab (Avastin)]. The patient's response to treatment has been [Stable disease], with tumor progression being [Probable], occurring at [right medial temporal lobe with surrounding FLAIR hyperintensity, likely residual tumor].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.49it/s, est. speed input: 9648.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.8 x 2.9 x 3.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [treatment related changes vs tumor progression], with tumor progression being [Probable], occurring at [left temporal resection cavity, extending to the margin of the left lateral ventricle and involving the white matter of the left temporal and occipital lobes, extending into the splenium of the corpus callosum, hippocampal commissures, posterior limb of the internal capsule and external capsule].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [6 x 5.1 x 5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80%].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [superior margin of the left frontotemporal resection cavity within left frontal operculum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left parahippocampal gyrus and hippocampus, left temporal stem and white matter, and left frontal lobe white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.6 x 3.5 x 3.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [33], and Karnofsky Performance Status (KPS) is [80-90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal and temporal lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [31 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right anterior to mid corpus callosum, right anterior frontal lobe, and right caudate head].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [20 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [5940 cGy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [tolerating radiation and chemotherapy well], with tumor progression being [Noted], occurring at [posterior margin of the resection cavity and surrounding areas including the hippocampal tail with extension into the splenium of the corpus callosum, residual hippocampal head the amygdala, and parahippocampal gyrus].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.53it/s, est. speed input: 9383.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior-inferior temporal lobe, insular cortex, right temporal operculum, right temporal stem, and medially into the head and body of the right hippocampus and fibers of the right anterior commissure], and is characterized as [Aplastic Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [43 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right anteromedial temporal lobe, right insula, and right orbitofrontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula, left inferior frontal gyrus, left superior temporal gyrus, left hypothalamus], and is characterized as [Anaplastic Astrocytoma]. The tumor measures [8.4 x 7.4 x 6.4 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [46 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Absent], ATRX status of [Lost], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [posterior, medial, and inferior aspects of the resection cavity involving the left striatum and the left temporal stem].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Anaplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [65], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Negative], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right ventral medial thalamus and hypothalamus, crossing the midline, with patchy confluent contrast enhancement].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal, parietal, and insular cortex], and is characterized as [Anaplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. PTEN deletion was also noted as [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left anterior and medial temporal lobe and insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe, amygdala, hippocampus, fornix, hippocampal commissure, column, anterior commissure, and anterior parietal lobe], and is characterized as [Astrocytoma]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [III]. The patient's age is [50 years], and Karnofsky Performance Status (KPS) is [50].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Negative], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior and posterior to the left temporal surgical cavity and left prepontine cistern].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right anterior temporal lobe and temporal stem, temporal stem, right temporal operculum, right insula, right anterior perforated substance, right optic chiasm and optic tract, right hippocampus and amygdala, right uncus, right thalamus, right dorsal midbrain and cerebral peduncle], and is characterized as [Anaplastic astrocytoma with prominent gemistocytic features, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive/Negative not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right insula, thalamus and remnant temporal lobe posterior to the resection matches preoperative FLAIR signal abnormality, consistent with residual infiltrative tumor].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.38it/s, est. speed input: 9372.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the medial right superior frontal lobe, and is characterized as Glioblastoma. The tumor measures 5.3 x 7.6 x 6.8 cm, with a grade of IV. The WHO grade is IV. The patient's age is 60 years, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Right frontal craniotomy for tumor resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Probable, occurring at the genu of the corpus callosum and extending into the right frontal lobe.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right frontal lobe, and is characterized as Glioblastoma, WHO grade IV. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 50, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Stable, with tumor progression being Noted, occurring at Right posterior frontal and temporal lobes.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right inferior frontal lobe, and is characterized as Glioblastoma. The tumor measures 2.4 x 1.8 x 2.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 51, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of wildtype, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification Present. The patient had a biopsy, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been significant response, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma (Astrocytoma WHO grade IV)]. The tumor measures [5.3x5.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Not specified], occurring at [Not specified].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [6.2 x 5.2 x 5.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [71 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Not amplified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the superior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the Right frontal lobe, and is characterized as Glioblastoma, WHO grade IV astrocytoma. The tumor measures 6.2 x 4.2 x 5.6 cm, with a grade of IV. The WHO grade is IV. The patient's age is 72 years, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion Not Specified, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Absent. The patient had a Near Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been improving, with tumor progression being Probable, occurring at the Right frontal lobe resection cavity and possibly a second site of disease along the medial aspect of the left occipital horn.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.17it/s, est. speed input: 9793.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left thalamus], and is characterized as [Glioblastoma]. The tumor measures [5 x 6 x 5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [70%].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [improved], with tumor progression being [Noted], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left thalamus], and is characterized as [Glioblastoma]. The tumor measures [3.2 x 2.5 x 2.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [75], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left thalamus extending to the posteriosuperior aspect of the left midbrain and tectum plate, posterior portion of the left superior temporal gyrus and occipital lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right thalamus], and is characterized as [Glioblastoma]. The tumor measures [3.7 x 3.4 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [32 years], and Karnofsky Performance Status (KPS) is [60]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Surgery Type, Biopsy only], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, non-progressive disease], with tumor progression being [Noted], occurring at [right thalamus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [thalamus], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as the patient was on a heat shock protein vaccine trial.\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Probable], occurring at [the splenium, and right dorsomedial thalamus and periatrial white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left thalamus extending into the left midbrain and third ventricle], and is characterized as [Glioblastoma]. The tumor measures [4.0 x 2.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [mixed response with decreased size, enhancement, and surrounding FLAIR abnormality of supratentorial disease centered in the left thalamus with progressed enhancing infratentorial disease in the inferior aspect of the fourth ventricle], with tumor progression being [Noted], occurring at [infratentorial disease in the inferior aspect of the fourth ventricle and extending through the foramen of Magendie with associated increased medullary FLAIR hyperintensity].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left thalamic region], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [4.9 x 3.9 x 5.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [residual enhancing subependymal tumor extending along the left lateral ventricle and nonenhancing tumor centered in the left thalamus].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.60it/s, est. speed input: 9633.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63], and Karnofsky Performance Status (KPS) is [70]. Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the corpus callosum and involving the body and splenium of the corpus callosum, particularly in the aspect inferolateral to the resection cavity, with increased extent of surrounding FLAIR hyperintensity as well as periventricular FLAIR hyperintensity, extending into the fornices bilaterally].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right parietal lobule], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Right parietal region extending into the right splenium of the corpus callosum and across to the left periventricular white matter].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right middle and inferior temporal gyri as well as parahippocampal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.6 x 4.5 x 3.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right splenium of the corpus callosum, right periatrial white matter, right thalamus, and right occipital lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right precuneus, cuneus, splenium of the corpus callosum, and the medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right cuneus, splenium of the corpus callosum and tracking down the right medial temporal lobe (hippocampal and parahippocampal gyrus involvement)].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.9 x 2.5 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right parieto-occipital lobes, right frontal lobe, and right cerebellum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [parieto-occipital region extending into the splenium of the corpus callosum, posterior cingulate and precuneus, and extending into the temporal stem and parahippocampal gyrus], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [70-90 as it varies across the notes].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [mixed response], with tumor progression being [Noted], occurring at [right anterior cingulate gyrus and surrounding the resection cavity].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.43it/s, est. speed input: 9510.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cingulate gyrus], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Probable], occurring at [medial and deep margins of the resection cavity in the left posterior frontal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula and mesial temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [3.2 x 4.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ) - although the patient was unable to tolerate it due to nausea]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and mesial temporal lobe, extending into the left hippocampal body and tail].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe, extending along the lateral ventricle towards the parietal lobe and superiorly to the left prefrontal cortex], and is characterized as [Glioblastoma (astrocytoma WHO grade IV)]. The tumor measures [4.4 x 3.2 x 2.4 cm in the left anterior temporal lobe and 2.6 x 3.3 x 1.7 cm in the left prefrontal cortex], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe and inferior region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [77 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left periatrial white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe, specifically the medial left superior parietal lobule and posterior cingulate and precuneal regions], and is characterized as [Glioblastoma (Astrocytoma, WHO Grade IV)]. The tumor measures [not specified], with a grade of [III on initial frozen section, later confirmed as IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [90 at last follow-up].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.40 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] in the form of a [vaccine study targeting EGFR].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the splenium of the corpus callosum and within the left frontal lobe, with new areas of nodular enhancement within the right aspect of the splenium].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left hypothalamus and septum pellucidum], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [4.1 x 2.5 cm (CC x TV)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [30 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Biopsy brain stereotactic], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left hypothalamus and septum pellucidum with adjacent mass effect, subependymal nodules along the lateral ventricular margins, and increased conspicuity of hyperdensity along the tentorium possibly representing subdural hemorrhage].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.44it/s, est. speed input: 9795.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe and left parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the anterior margin of the resection cavity with a 12 x 7 mm residual nodule of enhancing tissue and adjacent tissue demonstrating diffusion restriction].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.1 x 2.6 x 2.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [52 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Present], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [anterior aspect of resection cavity and right occipital lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal occipital region], and is characterized as [Glioblastoma, IDH-wildtype]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90 initially, later 80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Near Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [posterior superior aspect of the resection cavity as well as slightly enhancing nodule just superior to this, and along the resection cavity].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [the deep margin of the resection cavity extending to the left atrial ventricular surface as well as the inferior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma]. The tumor measures [2.9 x 2.5 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right parieto-occipital lobes, right frontal lobe, and right cerebellum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [occipital lobe (cuneus/lingual gyrus)], and is characterized as [Glioblastoma]. The tumor measures [2.9 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [51 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [inferior and medial to the resection cavity within the occipital lobe].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.45it/s, est. speed input: 9144.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior temporal lobe within the superior temporal gyrus], and is characterized as [Glioblastoma]. The tumor measures [2 cm AP x 1.8 cm transverse x 1.9 cm craniocaudal], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [L > R mesial temporal lobe, without enhancement, with linear restricted diffusion, that is concerning for post-ictal changes].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [6 x 5.1 x 5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80%].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [superior margin of the left frontotemporal resection cavity within left frontal operculum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.5 x 5.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Left frontal craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [right precentral gyrus with minimal postcentral gyrus involvement].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [up to 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [awake craniotomy with speech mapping, tumor resection, temporal and occipital], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left temporal stem and left lateral occipital lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [insular, parietal, and temporal lobes], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for open biopsy; possible microdissection/neuro navigation (Craniotomy)], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and parietal and temporal lobes, as well as left hemisphere deep white matter, cuneus, and left thalamus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [posterior aspect of the left superior and middle temporal lobes], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Left frontotemporal craniotomy for resection of brain tumor with intraoperative speech and motor mapping under brain lab image guidance], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [6 weeks] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as part of a clinical trial with [nivolumab].\n",
      "\n",
      "The patient's response to treatment has been [complicated by myelosuppression and seizures], with tumor progression being [Noted], occurring at [leptomeningeal spread within the left hemisphere, bilateral internal auditory canals, along the left cerebral peduncle and interpeduncular fossa, and along the visualized upper cervical cord].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.22it/s, est. speed input: 8992.5\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [medial and anterior aspects of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] but discontinued due to transaminitis.\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left posterior temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.6 x 3.5 x 3.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [33], and Karnofsky Performance Status (KPS) is [80-90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporaloccipital region], and is characterized as [Glioblastoma]. The tumor measures [Size in cm not specified], with a grade of [Grade not specified]. The WHO grade is [IV]. The patient's age is [81 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40 Gy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [stable], with tumor progression being [Absent], occurring at [Tumor Progression Location not specified due to absence of noted or probable progression].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [posterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [50], and Karnofsky Performance Status (KPS) is [70-80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [Present], and EGFR amplification [Absent]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [left superior frontal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [Left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.18it/s, est. speed input: 9961.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula and frontal operculum], and is characterized as [Glioblastoma]. The tumor measures [7.8 (AP) x 5.2 (CC) x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [33 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the frontal lobe, and is characterized as Glioblastoma. The tumor measures 2.5 x 2.2 cm, with a grade of IV. The WHO grade is IV. The patient's age is 52, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated (index=2), 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was not used as the patient refused Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been post-XRT, with tumor progression being Noted, occurring at the left centrum semiovale extending into the basal ganglia, thalamus, and along the corticospinal tracts descending through the brainstem to the cervicomedullary junction.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the medial right superior frontal lobe, and is characterized as Glioblastoma. The tumor measures 5.3 x 7.6 x 6.8 cm, with a grade of IV. The WHO grade is IV. The patient's age is 60 years, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Right frontal craniotomy for tumor resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Probable, occurring at the genu of the corpus callosum and extending into the right frontal lobe.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending to the level of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [4.1 x 4.7 x 4.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [83], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable with treatment change v tumor], with tumor progression being [Probable], occurring at [left postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the insular region, and is characterized as Glioblastoma. The tumor measures approximately 5 x 6 x 4.5 cm, with a grade of IV. The WHO grade is IV. The patient's age is 64, and Karnofsky Performance Status (KPS) is 70. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been mixed, with tumor progression being Noted, occurring at the left insular region.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Left hemisphere, specifically in the left frontal white matter and insula, and is characterized as Glioblastoma. The tumor measures 5.7 x 4.8 x 4.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 51 years, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion Not specified, ATRX status of Not specified, TERT promoter mutation Not specified, and EGFR amplification Absent.\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of Not specified over Not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been Not specified, with tumor progression being Noted, occurring at the anterior body of the corpus callosum extending into the right frontal white matter.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.14it/s, est. speed input: 10045.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [4.3 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [27 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. PTEN deletion testing by FISH was [Negative for PTEN deletion].\n",
      "\n",
      "The patient had a [Right parietal craniotomy, navigation microdissection motor mapping, tumor removal], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [Minimal infiltrative T2 FLAIR hyperintensity at the anterior margin of the resection cavity, adjacent to the atrium of the right lateral ventricle, which may represent a small amount of residual nonenhancing tumor].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [brainstem, pons], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [5 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, not specified], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Etoposide]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [leptomeningeal spread throughout the brain and proximal cervical spine].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal and parietal lobes, as well as left insula], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [14 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Left mini craniotomy for brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right frontal, temporal, and parietal periventricular white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the medial inferior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [Retained], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [mesial parietal area], and is characterized as [Aplastic astrocytoma, WHO Grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [43 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Loss of protein expression (positive result)], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [not specified].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.00it/s, est. speed input: 9938.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right medial temporal lobe, insular region, and hippocampus], and is characterized as [Glioblastoma]. The tumor measures [3.9 x 3.4 x 3.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right medial temporal lobe, insular region, and hippocampus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [approximately 3.8 x 2.6 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [60-80, as it varied over the course of treatment].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4005 cGy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used, but discontinued after progression].\n",
      "\n",
      "The patient's response to treatment has been [Stable, treatment effects], with tumor progression being [Noted], occurring at [right posterior frontal resection cavity and surrounding areas].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe, right middle frontal gyrus, right anterior cingulate gyrus, and right temporal stem], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [72], and Karnofsky Performance Status (KPS) is [50]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right frontal periventricular and subcortical white matter, right anterior parietal white matter, right white matter, corpus callosum, anterior limb of the internal capsule, right caudate, bilateral thalami, pons, midbrain, right occipital and parietal white matter extending to the vertex].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right insular cortex and right frontal operculum], and is characterized as [Glioblastoma]. The tumor measures [5.3 x 4.1 x 4.2 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled with noted improvement], with tumor progression being [Noted], occurring at [right insular cortex and right frontal operculum].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.55it/s, est. speed input: 9489.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [pons], and is characterized as [Astrocytoma, specifically a diffuse intrinsic pontine glioma]. The tumor measures [3.9 x 4.9 x 4.1 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [8 years], and Karnofsky Performance Status (KPS) is [70-100, as the patient is active with minor restrictions in physically strenuous play].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [5400 cGy] over [30] fractions. Chemotherapy drug was [Not specified, but the patient was on a clinical trial with an investigational drug]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [clinically improved], with tumor progression being [Probable], occurring at [the pons with increased size of pontine mass, mostly due to enlargement of cysts and new cysts, which may be treatment-related].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [pons, right anterior cingulate gyrus, right medial temporal lobes and hippocampal cortex, and right medial thalamus], and is characterized as [Diffuse midline glioma, H3 K27M-mutant, WHO grade IV]. The tumor measures [Size not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [70]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified]. The patient had a [Right frontal craniotomy for tumor biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [suggestive of treatment response], with tumor progression being [Noted], occurring at [pontine mass with heterogeneous enhancement, now demonstrating more central cavitation and peripheral enhancement, with decreased cerebral blood flow and amount of reduced diffusion].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left dorsal pons/brachium pontis, and is characterized as Diffuse midline glioma, H3 K27M-mutant, WHO grade IV. The tumor measures initially 3.3 cm x 3.4 cm x 3.7 cm, with a grade of IV. The WHO grade is IV. The patient's age is 3 years, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a biopsy, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 54 Gy over 30 fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the midbrain and leptomeningeal regions.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Not specified], specifically in the [pons], and is characterized as [Diffuse midline glioma, H3 K27M mutant, WHO Grade IV]. The tumor measures [2.9 cm at the pons, 3.8 x 2.8 cm with hemorrhage], with a grade of [Not specified]. The WHO grade is [IV]. The patient's age is [6 years], and Karnofsky Performance Status (KPS) is [Not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified]. The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [pons, midbrain, and cerebellar hemispheres].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [dorsal pons and involving the midbrain, tectum, and left brachium pontis], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [3 x 3.1 x 4.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [11 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [vorinostat]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior and inferior margins of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [pons], and is characterized as [Diffuse Infiltrating Pontine Glioma]. The tumor measures [3.5 x 5.1 x 3.9 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [7 years], and Karnofsky Performance Status (KPS) is [90 initially, later 70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [54 Gy] over [27] fractions. Chemotherapy drug was [Panobinostat, Everolimus, and Mebendazole]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Progression], with tumor progression being [Noted], occurring at [pons with increased size of the enhancing component and development of hydrocephalus].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.58it/s, est. speed input: 9637.3\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [pons, midbrain, right middle cerebellar peduncle, right cerebral peduncle, and right brachium pontis], and is characterized as [Astrocytoma, specifically anaplastic astrocytoma]. The tumor measures [approximately 2.5 x 3.1 x 2.3 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [4 years], and Karnofsky Performance Status (KPS) is [100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Bevacizumab (Avastin)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [positive, with significant reduction in the extent of T2 FLAIR signal abnormality], with tumor progression being [Noted], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cerebellar hemisphere, left pons, brachium pontis, and left cerebral peduncle], and is characterized as [Infiltrating astrocytoma, suspect high-grade astrocytoma]. The tumor measures [2.3 x 1.7-cm in greatest transaxial dimension], with a grade of [suspected high-grade, but specimen too small for accurate grading]. The WHO grade is [not specified]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Left suboccipital burr hole for tumor biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left pons, brachium pontis, and left cerebellar hemisphere].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [brainstem, left middle cerebral peduncle, and dorsal pons], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [32 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Left suboccipital burr hole for brain lab guided stereotactic biopsy of brainstem glioma], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [dorsal medulla, cerebellar peduncles, dorsal pons, and left cerebral peduncle consistent with pathologic diagnosis of aplastic astrocytoma with decreased expansile mass effect of the pons and medullary is appreciated on sagittal FLAIR sequence. Findings consistent with treatment response].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [44 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the medial inferior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [4th ventricle right cerebellar peduncle], and is characterized as [High-grade astrocytoma, consistent with at least WHO grade III]. The tumor measures [Size not specified], with a grade of [Grade not specified]. The WHO grade is [III]. The patient's age is [1 year], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Negative].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Cyclophosphamide, Cisplatin, Vincristine, and Methotrexate (MTX)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [No response to cycle of chemo], with tumor progression being [Not specified], occurring at [Not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left middle cerebellar peduncle with extension into the left cerebellar hemisphere, left lateral pons, and left posterior lateral medulla], and is characterized as [Aplastic Astrocytoma]. The tumor measures [Size not specified], with a grade of [Grade III]. The WHO grade is [III]. The patient's age is [41 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Suboptimal sample yielded low quality DNA; repeated efforts to analyze this specimen have been unsuccessful], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Negative for EGFR Amplification].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left brachium pontis extending into the deep cerebellar white matter and pontomedullary junction].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.53it/s, est. speed input: 9848.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior superior temporal lobe and insula, and anterior inferior left temporal lobe], and is characterized as [Aplastic pleomorphic xanthoastrocytoma, WHO grade III]. The tumor measures [3.7 AP x 2.6 x 3.1 CC mm and 3.0 AP x 2.1 x 1.6 CC cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [79], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [Not specified].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [pleomorphic xanthoastrocytoma with anaplastic features]. The tumor measures [5.8 x 4.2 x 4.1 cm], with a grade of [not specified]. The WHO grade is [not specified]. The patient's age is [25 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [36 Gy to the craniospinal axis with a boost to 60 Gy to the primary and lumbar sites] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [stable imaging], with tumor progression being [Noted], occurring at [lumbar spine].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic oligoastrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [39 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [right frontal craniotomy with motor mapping for tumor resection, Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [4.3 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [27 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. PTEN deletion testing by FISH was [Negative for PTEN deletion].\n",
      "\n",
      "The patient had a [Right parietal craniotomy, navigation microdissection motor mapping, tumor removal], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [Minimal infiltrative T2 FLAIR hyperintensity at the anterior margin of the resection cavity, adjacent to the atrium of the right lateral ventricle, which may represent a small amount of residual nonenhancing tumor].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Frontal/Thalamic and Parietal Lobe, and is characterized as Aplastic Astrocytoma. The tumor measures not specified, with a grade of III. The WHO grade is III. The patient's age is 65, and Karnofsky Performance Status (KPS) is 60. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Surgery Type, biopsies only, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been mixed, with tumor progression being Noted, occurring at Right thalamus and new focal zones of signal abnormality involving the periventricular white matter adjacent to the right frontal horn.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the right parieto-occipital region, and is characterized as aplastic pleomorphic xanthoastrocytoma. The tumor measures up to 7.0 cm, with a grade of III. The WHO grade is III. The patient's age is 57 years, and Karnofsky Performance Status (KPS) is 80%.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 5,940 cGy over 33 fractions. Chemotherapy drug was not specified, but there is mention of potential concurrent and adjuvant chemotherapy with temozolomide being discussed. Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Absent, occurring at not specified.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.54it/s, est. speed input: 9329.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Absent], ATRX status of [Retained], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [59.4 Gy] over [33] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right postcentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Frontal Lobe, and is characterized as Aplastic Astrocytoma. The tumor measures not specified, with a grade of III. The WHO grade is Grade-3. The patient's age is 23, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Craniectomy craniotomy for excision of brain tumor, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Stable, with tumor progression being Probable, occurring at the right frontal corona radiata and extending into the anterior right cingulate gyrus and genu of the corpus callosum.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left middle frontal gyrus], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [36 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Loss], TERT promoter mutation [not specified], and EGFR amplification [not specified]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left middle frontal gyrus with residual nonenhancing tumor extending into the body of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe, motor cortex, and straddling the corpus callosum], and is characterized as [Aplastic Astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [34 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [significant interval response to treatment manifested by markedly decreased masslike FLAIR abnormality], with tumor progression being [Probable], occurring at [precentral gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Frontal/Thalamic and Parietal Lobe, and is characterized as Aplastic Astrocytoma. The tumor measures not specified, with a grade of III. The WHO grade is III. The patient's age is 65, and Karnofsky Performance Status (KPS) is 60. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Surgery Type, biopsies only, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been mixed, with tumor progression being Noted, occurring at Right thalamus and new focal zones of signal abnormality involving the periventricular white matter adjacent to the right frontal horn.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the Right middle frontal gyrus, and is characterized as Aplastic astrocytoma. The tumor measures 4.1 cm, with a grade of III. The WHO grade is III. The patient's age is 27, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 negative, but IDH-1 and IDH-2 sequencing pending), MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of Lost (Negative), TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been stable imaging, with tumor progression being Absent, occurring at not specified.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.15it/s, est. speed input: 10024.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe and left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [79 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left temporal lobe and left frontal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [posterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [50], and Karnofsky Performance Status (KPS) is [70-80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [Present], and EGFR amplification [Absent]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [left superior frontal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal and temporal lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [31 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right anterior to mid corpus callosum, right anterior frontal lobe, and right caudate head].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [Left Temporal, parietal, frontal lobe, Right frontal lobe and splenium], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Biopsy only], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [corpus callosum and left temporal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left posterior temporal lobe], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the anteromedial resection margin and increasing white matter FLAIR signal abnormality in the left temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe, left frontal operculum, and posterior cingulate gyrus], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [39 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left posterior cingulate gyrus and left peri-atrial white matter].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.97it/s, est. speed input: 9689.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [6.2 x 5.2 x 5.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [71 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Not amplified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the superior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right anterior temporal lobe], and is characterized as [Glioblastoma, (Astrocytoma WHO Grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Absent], occurring at [not applicable].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe, including the hippocampus and middle temporal gyrus], and is characterized as [Glioblastoma, Astrocytoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe, extending along the lateral ventricle towards the parietal lobe and superiorly to the left prefrontal cortex], and is characterized as [Glioblastoma (astrocytoma WHO grade IV)]. The tumor measures [4.4 x 3.2 x 2.4 cm in the left anterior temporal lobe and 2.6 x 3.3 x 1.7 cm in the left prefrontal cortex], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe and inferior region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal lobe], and is characterized as [Glioblastoma, (Astrocytoma WHO grade IV)]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [IV]. The patient's age is [58 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Improved], with tumor progression being [Noted], occurring at [superior to the resection cavity and extending across the genu of the corpus callosum into the left periatrial white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [posterior right temporal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [7.0 x 4.4 cm], with a grade of [not specified]. The WHO grade is [IV]. The patient's age is [70 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [CCNU (Lomustine)] and [Avastin (Bevacizumab) - limited to 1 dose due to invasion]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe, parietal and occipital lobes with anterior extension along the internal and external capsules, as well as the right cerebri of the midbrain, and superiorly to involve the right inferior and superior parietal lobule].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.49it/s, est. speed input: 9495.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the brainstem, specifically in the medulla, pons, midbrain, cerebellar peduncles, cerebellar hemispheres, cerebral peduncles, bilateral internal capsules, bifrontal and biparietal white matter with involvement of the left parietal cortex, left temporal lobe, both insulae, splenium, optic chiasm and optic radiations, and is characterized as Diffuse Intrinsic Pontine Glioma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 8 years, and Karnofsky Performance Status (KPS) is not specified.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified.\n",
      "\n",
      "The patient had a biopsy, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the right brachium pontis and left frontal and parietal lobes.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [pons], and is characterized as [Astrocytoma, specifically a diffuse intrinsic pontine glioma]. The tumor measures [3.9 x 4.9 x 4.1 cm], with a grade of [III]. The WHO grade is [III]. The patient's age is [8 years], and Karnofsky Performance Status (KPS) is [70-100, as the patient is active with minor restrictions in physically strenuous play].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Stereotactic biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [5400 cGy] over [30] fractions. Chemotherapy drug was [Not specified, but the patient was on a clinical trial with an investigational drug]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [clinically improved], with tumor progression being [Probable], occurring at [the pons with increased size of pontine mass, mostly due to enlargement of cysts and new cysts, which may be treatment-related].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [brainstem, pons], and is characterized as [Aplastic astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [5 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, not specified], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Etoposide]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [leptomeningeal spread throughout the brain and proximal cervical spine].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [brainstem, left middle cerebral peduncle, and dorsal pons], and is characterized as [Aplastic astrocytoma]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [32 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Left suboccipital burr hole for brain lab guided stereotactic biopsy of brainstem glioma], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [dorsal medulla, cerebellar peduncles, dorsal pons, and left cerebral peduncle consistent with pathologic diagnosis of aplastic astrocytoma with decreased expansile mass effect of the pons and medullary is appreciated on sagittal FLAIR sequence. Findings consistent with treatment response].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Brainstem], specifically in the [pons of the brainstem], and is characterized as [Astrocytoma, most consistent with anaplastic astrocytoma, WHO grade III]. The tumor measures [not specified], with a grade of [III]. The WHO grade is [III]. The patient's age is [7 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified]. The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [5400 cGy] over [30] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [improvement], with tumor progression being [Noted], occurring at [suprasellar region and along the surface of the spinal cord, most prominent dorsally from C6-T5 and within the cauda equina].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the brainstem, specifically in the pons, and is characterized as a diffuse intrinsic pontine glioma (DIPG). The tumor measures not specified, with a grade of III. The WHO grade is III. The patient's age is 4 years, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a biopsy, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the right thalamus.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.51it/s, est. speed input: 9397.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [56 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the deep lateral aspect of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.6 x 6.2 x 4.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right lateral ventricular atrium posterior horn and possibly subependymal spread of disease].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right suprasylvian posterior frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [3.9 x 2.7 x 2.2 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [78 years], and Karnofsky Performance Status (KPS) is [30-40].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Surgery Type, Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [53.35 Gy] over [25] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal, parietal, and temporal lobes].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [approximately 3.8 x 2.6 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [60-80, as it varied over the course of treatment].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4005 cGy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used, but discontinued after progression].\n",
      "\n",
      "The patient's response to treatment has been [Stable, treatment effects], with tumor progression being [Noted], occurring at [right posterior frontal resection cavity and surrounding areas].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe just above the sylvian fissure], and is characterized as [Glioblastoma]. The tumor measures [4.3 x 4.2 x 5.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for resection of glioma with Neuro Navigation (Craniotomy)], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Absent], occurring at [Not applicable].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.98it/s, est. speed input: 9958.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe], and is characterized as [Glioblastoma, Astrocytoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [76], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Probable], occurring at [left temporal fissure].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left anterior temporal lobe, extending along the lateral ventricle towards the parietal lobe and superiorly to the left prefrontal cortex], and is characterized as [Glioblastoma (astrocytoma WHO grade IV)]. The tumor measures [4.4 x 3.2 x 2.4 cm in the left anterior temporal lobe and 2.6 x 3.3 x 1.7 cm in the left prefrontal cortex], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [47 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe and inferior region].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left insula and mesial temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [3.2 x 4.1 x 3.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ) - although the patient was unable to tolerate it due to nausea]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and mesial temporal lobe, extending into the left hippocampal body and tail].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporoparietal lobe involving the left inferior parietal lobule and left temporal lobe], and is characterized as [Glioblastoma, WHO grade IV astrocytoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [38 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Not amplified]. The patient had a [Near Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO grade IV)]. The tumor measures [4.5 cm AP x 2.5 cm TV x 2.5 cm SI], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Left temporal craniotomy for tumor resection with awake speech mapping, Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [controlled], with tumor progression being [Probable], occurring at [left temporal lobe resection cavity with a thicker enhancing rim].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left medial temporal lobe], and is characterized as [Glioblastoma (Astrocytoma, WHO Grade IV)]. The tumor measures [6.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [54 Gy] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [left medial temporal lobe, left hippocampus, posterior limb of internal capsule, and left region].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.46it/s, est. speed input: 9433.2\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left inferior parietal lobule/angular gyrus, and is characterized as Glioblastoma. The tumor measures 3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 67, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of Positive, TERT promoter mutation not specified, and EGFR amplification Absent.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been stable, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left parietal lobe, and is characterized as Glioblastoma. The tumor measures 1.5 cm, with a grade of IV. The WHO grade is IV. The patient's age is 60, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 immunohistochemistry is negative), MGMT promoter methylation status of Unmethylated (Suboptimal sample yielded low quality DNA), 1p/19q co-deletion Absent (not specified), ATRX status of Positive (not specified), TERT promoter mutation Absent (not specified), and EGFR amplification Present (Positive for EGFR Amplification).\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 6 weeks. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the left superior parietal lobule and posterior aspect of the left superior temporal gyrus.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior parietal lobule], and is characterized as [Glioblastoma, (Astrocytoma, WHO grade IV)]. The tumor measures [3.5 x 3.2 x 3.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [anterior to the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left inferior parietal lobule, including postcentral gyrus and extending into the precentral gyrus], and is characterized as [Glioblastoma (Astrocytoma WHO grade IV)]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left superior parietal lobule and anterior to the resection bed].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left parieto-occipital region, and is characterized as Glioblastoma. The tumor measures 4.1 x 5.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 82 years, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1: Negative), MGMT promoter methylation status of Methylated (MGMT Promoter Methylation Assay: Positive), 1p/19q co-deletion not specified, ATRX status of Positive (Immunohistochemical stains for ATRX: Positive), TERT promoter mutation not specified, and EGFR amplification Absent (EGFR amplification testing by FISH: Negative for EGFR Amplification). The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the deep margin of the resection proximate to the ventricular trigone and left inferior frontal gyrus.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Left hemisphere, specifically in the inferior parietal lobule, and is characterized as Glioblastoma. The tumor measures 2.9 cm, with a grade of IV. The WHO grade is IV. The patient's age is 49, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of wildtype, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was not specified. Immunotherapy was Used.\n",
      "\n",
      "The patient's response to treatment has been stable, with tumor progression being Noted, occurring at the left inferior parietal lobule resection cavity with new focus of nodular enhancement medial to the cavity.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.12it/s, est. speed input: 10084.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right inferior and middle right frontal gyri, and is characterized as Glioblastoma. The tumor measures 6.2 x 4.7 cm, with a grade of IV. The WHO grade is IV. The patient's age is 44, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 WT), MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification Present. PTEN deletion is also noted as Positive.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over a number of fractions not specified. Chemotherapy drug was Temozolomide (TMZ).\n",
      "\n",
      "Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been stable with minimal changes on imaging, with tumor progression being Probable, occurring at the inferior aspect of the right inferior frontal gyrus resection cavity.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right inferior frontal lobe, and is characterized as Glioblastoma. The tumor measures 2.4 x 1.8 x 2.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 51, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of wildtype, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification Present. The patient had a biopsy, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been significant response, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the cingulate gyrus, and is characterized as Glioblastoma. The tumor measures 1.5 x 1.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 61, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification Present. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been stable with tumor progression being Probable, occurring at the right cingulate gyrus and subcortical white matter of the right superior frontal gyrus.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right middle frontal gyrus, and is characterized as Glioblastoma. The tumor measures 4.2 x 4.5 x 4.0 cm, with a grade of IV. The WHO grade is IV. The patient's age is 57 years, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification not specified.\n",
      "\n",
      "The patient had a Craniotomy for Tumor Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been stable, with tumor progression being Noted, occurring at the resection cavity with significant edema.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the medial right superior frontal lobe, and is characterized as Glioblastoma. The tumor measures 5.3 x 7.6 x 6.8 cm, with a grade of IV. The WHO grade is IV. The patient's age is 60 years, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Right frontal craniotomy for tumor resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Probable, occurring at the genu of the corpus callosum and extending into the right frontal lobe.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the right inferior frontal gyrus and insula, and is characterized as Glioblastoma. The tumor measures 2.1 cm in diameter, with a grade of IV. The WHO grade is IV. The patient's age is 51 years, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been stable, with tumor progression being Noted, occurring at the right pulvinar nucleus of the thalamus.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.24it/s, est. speed input: 9793.4\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the temporal lobe, and is characterized as Glioblastoma. The tumor measures up to 4.7 x 2.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 78, and Karnofsky Performance Status (KPS) is 60.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of Positive, TERT promoter mutation not specified, and EGFR amplification Present.\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 6 weeks. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Noted, occurring at the right temporal resection cavity and involving the ependymal surface, as well as new sites of disease within the right hemisphere, including the right precentral gyrus.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Temporal Lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 55, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 -type), MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been tolerating well, with tumor progression being Probable, occurring at the resection cavity extending superiorly into the right parietal lobe and right posterior frontal lobes as well as medially into the right lateral aspect of the thalamus.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the right temporal lobe, and is characterized as Glioblastoma. The tumor measures 5 x 8 x 4.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 68, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Probable, occurring at the superior and medial margins of the resection cavity and increased extent of FLAIR hyperintensity.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior aspect of the right lateral temporal lobe, predominantly involving the superior and middle temporal gyri], and is characterized as [Glioblastoma]. The tumor measures [6.5 x 5.1 x 5.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [73 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right temporal and insular white matter, centrum semi-ovale, right parietal subcortical white matter, and extending into the thalamus, right corticospinal tract, right optic tract and optic chiasm].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Temporal Lobe, and is characterized as Glioblastoma. The tumor measures 6.3 x 4.8 cm, with a grade of IV. The WHO grade is IV. The patient's age is 54, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Not Specified, 1p/19q co-deletion Absent, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Present. The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over Not Specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Used. The patient's response to treatment has been Stable, with tumor progression being Absent, occurring at Not Specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the right temporal lobe, superior temporal gyrus, right internal capsule, right basal ganglia, and anterior commissure, and is characterized as Glioblastoma. The tumor measures 3.8 x 3.5 cm, with a grade of IV. The WHO grade is IV. The patient's age is 53 years, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Not Specified, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion Not Specified, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Absent. PTEN deletion (loss of chromosome 10) was Positive.\n",
      "\n",
      "The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of Not Specified over Not Specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been Not Specified, with tumor progression being Noted, occurring at the right temporal lobe surgical bed with marked increase in surrounding T2/FLAIR signal in the right frontal, parietal, and temporal lobe.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.01it/s, est. speed input: 10077.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cingulate gyrus, left posterior superior frontal gyrus, posterior body of the corpus callosum, and left splenium of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [60-80, as it varies across the notes].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present with Relative copy gain].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [stable with right side plegia and precarious platelet condition], with tumor progression being [Noted], occurring at [left frontal lobe extending along the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontoparietal lobe and corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [2.6 x 2.0 x 1.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [42 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Absent], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left lateral ventricle and corpus callosum, left parietal lobe, insula, deep gray nuclei, left cerebri, right fornix, and hippocampal commissure].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending into the corpus callosum, right frontal white matter, left basal ganglia, left cerebral peduncle, and anterior centrum semiovale and corona radiata], and is characterized as [Glioblastoma]. The tumor measures [3.2 x 3.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left frontal lobe, extending into the corpus callosum and right frontal white matter, and inferiorly involving the posterior limb of the left internal capsule, left cerebral peduncle, and superior portion of the left pons].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right middle and inferior temporal gyri as well as parahippocampal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.6 x 4.5 x 3.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right splenium of the corpus callosum, right periatrial white matter, right thalamus, and right occipital lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal/periatrial white matter], and is characterized as [Glioblastoma]. The tumor measures [3.5 x 2.3 x 2.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left paracentral and superior parietal lobules with extension along the deep frontoparietal white matter to the periventricular white matter and splenium of corpus callosum and across midline to the opposite right parietal lobe white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left periatrial white matter, extending medially into the splenium of the corpus callosum and into the tail of the left hippocampus, with additional areas of nonenhancing masslike FLAIR signal abnormality in the left middle and inferior temporal gyri], and is characterized as [Glioblastoma]. The tumor measures [2.8 x 4.8 x 2.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [54 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion was also [Present].\n",
      "\n",
      "The patient had a [Left parieto-occipital craniotomy for resection of glioblastoma under brain lab image guidance with intraoperative], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [the left splenium of the corpus callosum and the left greater than right fornices].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.25it/s, est. speed input: 9795.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the parietal region, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 69, and Karnofsky Performance Status (KPS) is not specified.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated (index = 13), 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. PTEN status is intact.\n",
      "\n",
      "The patient had a Right parietal craniotomy for resection of glioblastoma, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the posterior insula and superior temporal gyrus, and is characterized as Glioblastoma, WHO grade IV. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 48, and Karnofsky Performance Status (KPS) is 90 initially, but not specified after treatment. Key molecular markers include an IDH mutation status of Non-mutant (negative with the antibodies against IDH-1 R132H mutant protein), MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent (Negative for EGFR Amplification). The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the resection cavity extending to the surface of the right lateral ventricle, right temporal and parietal lobes, right caudate, right thalamus, right cerebral peduncle, right posterior limb of the internal capsule, and right optic tract and chiasm.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior and inferior parietal lobules], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [74], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Negative], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Absent], occurring at [not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the Right Temporal Lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 55, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 -type), MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been tolerating well, with tumor progression being Probable, occurring at the resection cavity extending superiorly into the right parietal lobe and right posterior frontal lobes as well as medially into the right lateral aspect of the thalamus.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the parieto-occipital lobe, and is characterized as Glioblastoma. The tumor measures 6.1 x 4.5 x 5.2 cm, with a grade of IV. The WHO grade is IV. The patient's age is 34, and Karnofsky Performance Status (KPS) is 90.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion Not Specified, ATRX status of Not Specified, TERT promoter mutation Not Specified, and EGFR amplification Absent.\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the resection cavity with increased peripheral enhancement and enlargement of the right parietal resection cavity, with increased T2/FLAIR signal abnormality compared to MRI from previous dates.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the right parietal lobule and posterior insula, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 70, and Karnofsky Performance Status (KPS) is 90 initially, later 80. Key molecular markers include an IDH mutation status of Non-mutant, MGMT promoter methylation status of Methylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been stable, with tumor progression being Noted, occurring at the right parietal resection cavity and right posterior insular glioblastoma.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.02it/s, est. speed input: 9963.1\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left parieto-occipital region, and is characterized as Glioblastoma. The tumor measures approximately 4.8 x 3.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 50 years, and Karnofsky Performance Status (KPS) is 80.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 wildtype), MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status not specified, TERT promoter mutation not specified, and EGFR amplification Present. PTEN deletion is also noted.\n",
      "\n",
      "The patient had a near Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been mixed, with tumor progression being Noted, occurring at the left periventricular region, splenium, and left parietal lobe.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal area], and is characterized as [Glioblastoma]. The tumor measures [2.1 x 2.7 cm in dimension and 2.1 cm in craniocaudal dimension], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [left parietal resection cavity with surrounding FLAIR hyperintensity and solid enhancement].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left parietal lobe, and is characterized as Glioblastoma. The tumor measures 1.5 cm, with a grade of IV. The WHO grade is IV. The patient's age is 60, and Karnofsky Performance Status (KPS) is 90. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1 immunohistochemistry is negative), MGMT promoter methylation status of Unmethylated (Suboptimal sample yielded low quality DNA), 1p/19q co-deletion Absent (not specified), ATRX status of Positive (not specified), TERT promoter mutation Absent (not specified), and EGFR amplification Present (Positive for EGFR Amplification).\n",
      "\n",
      "The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 6 weeks. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the left superior parietal lobule and posterior aspect of the left superior temporal gyrus.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left frontal and left parietal regions, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 57 years, and Karnofsky Performance Status (KPS) is 70. Key molecular markers include an IDH mutation status of not specified, MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion Absent, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Present (EGFR vIII mutated). The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Probable, occurring at the area inferior to the left frontal resection cavity with associated increased FLAIR and perfusion.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the parietal lobe, and is characterized as Glioblastoma. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 40, and Karnofsky Performance Status (KPS) is 80. Key molecular markers include an IDH mutation status of Mutant, MGMT promoter methylation status of not specified, 1p/19q co-deletion Absent, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been stable, with tumor progression being Absent, occurring at not specified.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Left hemisphere, specifically in the parietal region, and is characterized as Glioblastoma. The tumor measures approximately 4.0 x 3.6 x 3.4 cm, with a grade of IV. The WHO grade is IV. The patient's age is 79, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Wildtype, MGMT promoter methylation status of Methylated (index = 16), 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent. The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been Noted, with tumor progression being Noted, occurring at the left parietal resection cavity extending across the splenium to the right aspect of the corpus callosum.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.12it/s, est. speed input: 9951.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [L temporal], and is characterized as [Glioblastoma]. The tumor measures [Size in cm not specified], with a grade of [Grade not specified]. The WHO grade is [IV]. The patient's age is [36 years], and Karnofsky Performance Status (KPS) is [Score not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant not specified], MGMT promoter methylation status of [Unmethylated not specified], 1p/19q co-deletion [Absent not specified], ATRX status of [Positive/Negative not specified], TERT promoter mutation [Present/Absent not specified], and EGFR amplification [Present/Absent not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used/Not Used not specified].\n",
      "\n",
      "The patient's response to treatment has been [Response not specified], with tumor progression being [Noted/Absent/Probable not specified], occurring at [Tumor Progression Location not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [73 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Resection of right temporal lesion], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used], specifically [Nivolumab].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right thalamus involving the pulvinar].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right temporal lobe, right insula, right thalamus, and right corticospinal tract].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [L temporal region], and is characterized as [Glioblastoma]. The tumor measures [Size in cm not specified], with a grade of [Grade IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [ranging from 70 to 90 throughout the notes].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Not specified], MGMT promoter methylation status of [Not specified], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Not specified].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used as the patient is enrolled in a study involving a vaccine].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted/Absent/Probable not specified], occurring at [Tumor Progression Location not specified].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporaloccipital region], and is characterized as [Glioblastoma]. The tumor measures [Size in cm not specified], with a grade of [Grade not specified]. The WHO grade is [IV]. The patient's age is [81 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40 Gy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [stable], with tumor progression being [Absent], occurring at [Tumor Progression Location not specified due to absence of noted or probable progression].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [temporal region], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [73 years], and Karnofsky Performance Status (KPS) is [ranging from 80 to 90 throughout the notes].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Surgery Type, Gross Total Resection or Subtotal Resection not specified], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ) not specified as used or not]. Immunotherapy was [Used] as part of the BMS clinical trial with nivolumab.\n",
      "\n",
      "The patient's response to treatment has been [stable], with tumor progression being [Noted], occurring at [anteroinferior margin of the collapsed resection cavity as well as increased nodular enhancement and T2FLAIR hyperintensity consistent with treatment-related changes and steroid taper].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.51it/s, est. speed input: 9272.8\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior frontal gyrus, extending into the anterior body of the corpus callosum and caudate head], and is characterized as [Glioblastoma]. The tumor measures [2.4 x 2.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe and extending into the anterior body of the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right cingulate gyrus extending along the lateral genu of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [2.1 cm (transverse) x 3.1 cm (AP) x 2.4 cm (CC)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe, with surrounding edema-like FLAIR, consistent with high-grade glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right inferior frontal gyrus], and is characterized as [Glioblastoma]. The tumor measures [approximately 3.8 x 2.6 x 4.0 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [60-80, as it varied over the course of treatment].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Positive], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [4005 cGy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used, but discontinued after progression].\n",
      "\n",
      "The patient's response to treatment has been [Stable, treatment effects], with tumor progression being [Noted], occurring at [right posterior frontal resection cavity and surrounding areas].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [medial right frontal lobe, extending through the corpus callosum to involve the left cingulate gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.5 x 4.5 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [84 years], and Karnofsky Performance Status (KPS) is [70-80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated (index = 17)], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. PTEN deletion is also [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40 Gy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [right greater than left frontal lobe tumor with residual enhancement and persistent increased perfusion likely representing residual tumor].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.60it/s, est. speed input: 9691.6\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [postcentral gyrus and posterior aspect of the right frontal lobe], and is characterized as [Glioblastoma, WHO grade IV, IDH wildtype]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right parietal vertex cerebrum suspect for tumor recurrence or residual].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [anterior pole of the right frontal lobe], and is characterized as [Glioblastoma, IDH-wildtype, WHO grade IV]. The tumor measures [up to 2.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the genu of the corpus callosum, right cingulate gyrus, right posterior superior frontal gyrus, and ventral, medial aspect of the left thalamus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Right frontal lobe, insula, and basal ganglia, and right anterior temporal lobe], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [62 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [Right frontotemporal region with irregular rim enhancing resection cavity and associated edema].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Right hemisphere, specifically in the posterior insula and superior temporal gyrus, and is characterized as Glioblastoma, WHO grade IV. The tumor measures not specified, with a grade of IV. The WHO grade is IV. The patient's age is 48, and Karnofsky Performance Status (KPS) is 90 initially, but not specified after treatment. Key molecular markers include an IDH mutation status of Non-mutant (negative with the antibodies against IDH-1 R132H mutant protein), MGMT promoter methylation status of Unmethylated, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification Absent (Negative for EGFR Amplification). The patient had a Gross Total Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of 60 Gy over 30 fractions. Chemotherapy drug was Temozolomide (TMZ). Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the resection cavity extending to the surface of the right lateral ventricle, right temporal and parietal lobes, right caudate, right thalamus, right cerebral peduncle, right posterior limb of the internal capsule, and right optic tract and chiasm.\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right insula and anterior temporal lobe], and is characterized as [Glioblastoma, likely IDH-wildtype, WHO grade IV]. The tumor measures [7 x 5.3 x 5.2 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [66 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Pending], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not specified].\n",
      "\n",
      "The patient's response to treatment has been [Stable with treatment-related changes], with tumor progression being [Noted], occurring at [anteromedial margin of the right temporal resection cavity and slight interval increase in punctate areas of enhancement along the posteromedial margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [posterior right middle and superior temporal gyri], and is characterized as [Glioblastoma, IDH-wildtype, WHO Grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [60 years], and Karnofsky Performance Status (KPS) is [100].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [superior medial margin of the resection cavity].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.57it/s, est. speed input: 9709.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma, WHO Grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left temporal lobe and C5-C7 levels of the spinal cord].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [Left Frontal Lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [55 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Left Frontal Lobe extending to the genu of the corpus callosum].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [insular, parietal, and temporal lobes], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for open biopsy; possible microdissection/neuro navigation (Craniotomy)], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left insula and parietal and temporal lobes, as well as left hemisphere deep white matter, cuneus, and left thalamus].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the left frontal lobe, involving the genu of the corpus callosum and extending into the right frontal and right parietal white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [60-70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Present], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the right medial frontal gyrus and gyrus rectus along the posterior and inferior resection margins].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [Bilateral Fornices], and is characterized as [Glioblastoma, WHO grade IV]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [69 years], and Karnofsky Performance Status (KPS) is [70]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ) - planned but not confirmed if started]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [Bilateral Fornices with spread to the right hippocampus and other areas].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.06it/s, est. speed input: 10149.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.5 x 6.0 x 3.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [48 years], and Karnofsky Performance Status (KPS) is [90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [the right frontal resection cavity and possibly the left superior temporal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [45 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [not specified].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [posterior right frontal lobe with corresponding interval increase in thickness of the enhancing rim and FLAIR hyperintensity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [Frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [41 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Gross Total Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [superior to the right frontal resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [the genu of the corpus callosum and extending to the subcortical frontal lobe white matter and temporal stem].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [6.4 x 3.9 x 4.6 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [77 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40 Gy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [medial left frontal lobe near the left anterior falx].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Right hemisphere], specifically in the [frontal lobe], and is characterized as [Glioblastoma]. The tumor measures [5.6 x 6.1 x 4.3 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Probable], occurring at [bilateral frontal lobes with increased enhancement across the corpus callosum].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.00it/s, est. speed input: 9885.1\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right middle and inferior temporal gyri as well as parahippocampal gyrus], and is characterized as [Glioblastoma]. The tumor measures [5.6 x 4.5 x 3.1 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [65 years], and Karnofsky Performance Status (KPS) is [80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right splenium of the corpus callosum, right periatrial white matter, right thalamus, and right occipital lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left cingulate gyrus, left posterior superior frontal gyrus, posterior body of the corpus callosum, and left splenium of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [60-80, as it varies across the notes].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [not specified], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present with Relative copy gain].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [6000 cGy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [stable with right side plegia and precarious platelet condition], with tumor progression being [Noted], occurring at [left frontal lobe extending along the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right superior frontal gyrus, extending into the anterior body of the corpus callosum and caudate head], and is characterized as [Glioblastoma]. The tumor measures [2.4 x 2.1 x 4.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67], and Karnofsky Performance Status (KPS) is [60].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)].\n",
      "\n",
      "Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe and extending into the anterior body of the corpus callosum].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right cingulate gyrus extending along the lateral genu of the corpus callosum], and is characterized as [Glioblastoma]. The tumor measures [2.1 cm (transverse) x 3.1 cm (AP) x 2.4 cm (CC)], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [57 years], and Karnofsky Performance Status (KPS) is [80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [right frontal lobe, with surrounding edema-like FLAIR, consistent with high-grade glioma].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal lobe, extending into the corpus callosum, right frontal white matter, left basal ganglia, left cerebral peduncle, and anterior centrum semiovale and corona radiata], and is characterized as [Glioblastoma]. The tumor measures [3.2 x 3.5 x 4.8 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [63 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left frontal lobe, extending into the corpus callosum and right frontal white matter, and inferiorly involving the posterior limb of the left internal capsule, left cerebral peduncle, and superior portion of the left pons].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Midline], specifically in the [posterior aspect of the corpus callosum body with extension into bilateral cingulate gyri, right corticospinal tract, right medial thalamus and right posterior parahippocampal gyrus]. The tumor is characterized as [Glioblastoma]. The tumor measures [6.4 x 3.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [70-80].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [Not specified] over [Not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [Not specified], with tumor progression being [Noted], occurring at [splenium of the corpus callosum with extension to the subependymal surfaces of the bilateral lateral ventricles anteriorly and posteriorly, anterior aspect of the corpus callosum near the genu and rostrum, and bilateral centrum semiovale].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.36it/s, est. speed input: 9877.9\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the Left hemisphere, specifically in the left parieto-occipital region, and is characterized as Glioblastoma. The tumor measures 4.1 x 5.3 cm, with a grade of IV. The WHO grade is IV. The patient's age is 82 years, and Karnofsky Performance Status (KPS) is not specified. Key molecular markers include an IDH mutation status of Non-mutant (IDH-1: Negative), MGMT promoter methylation status of Methylated (MGMT Promoter Methylation Assay: Positive), 1p/19q co-deletion not specified, ATRX status of Positive (Immunohistochemical stains for ATRX: Positive), TERT promoter mutation not specified, and EGFR amplification Absent (EGFR amplification testing by FISH: Negative for EGFR Amplification). The patient had a Subtotal Resection, followed by radiation therapy/radiotherapy/RT with a total prescription/dose not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used. The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the deep margin of the resection proximate to the ventricular trigone and left inferior frontal gyrus.\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [posterior right cingulate gyrus extending into right parietal lobe white matter and right lateral splenium of corpus callosum], and is characterized as [Glioblastoma multiforme (Astrocytoma, WHO Grade IV)]. The tumor measures [4.1 x 3.4 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [68 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent]. The patient had a [Right sided occipital craniotomy for tumor resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [not specified]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [the margin of the resection cavity extending to and abuts the ependymal surface of the right lateral ventricle, with trapping of the occipital and temporal horns of the right lateral ventricle and extensive trans-ependymal FLAIR signal abnormality concerning for subependymal extension].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left occipital lobe], and is characterized as [Glioblastoma]. The tumor measures [5.0 x 3.7 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [67 years], and Karnofsky Performance Status (KPS) is [70].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [the deep margin of the resection cavity extending to the left atrial ventricular surface as well as the inferior margin of the resection cavity].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left parietal lobe extending into the occipital lobe and posterior temporal lobe], and is characterized as [Glioblastoma, NOS, WHO grade IV]. The tumor measures [up to 3.9 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [84 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Craniectomy for open brain biopsy], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40 Gy] over [15] fractions. Chemotherapy drug was [not used due to patient's choice]. Immunotherapy was [Not Used].\n",
      "\n",
      "The patient's response to treatment has been [post-radiation changes with worsening imaging appearance], with tumor progression being [Noted], occurring at [left parietal lobe and posterior temporal lobe].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Right hemisphere], specifically in the [right parietal and occipital lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [64 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Absent].\n",
      "\n",
      "The patient had a [Right parietal craniotomy for gross total resection of glioblastoma under image guidance], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used] as the patient was enrolled in a clinical trial of heat shock protein vaccine.\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [right inferior parietal lobule, and the inferior right post and pre-central gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the Right hemisphere, specifically in the occipital region, and is characterized as Glioblastoma with sarcomatous features. The tumor measures 2.2 cm in the trigone of the right lateral ventricle, with a grade of IV. The WHO grade is IV. The patient's age is 74, and Karnofsky Performance Status (KPS) is not specified.\n",
      "\n",
      "Key molecular markers include an IDH mutation status of Non-mutant (IDH-wildtype), MGMT promoter methylation status of not specified, 1p/19q co-deletion not specified, ATRX status of not specified, TERT promoter mutation not specified, and EGFR amplification not specified.\n",
      "\n",
      "The patient had a Right parieto-occipital craniotomy for resection of brain tumor with intraventricular extension, followed by radiation therapy/radiotherapy/RT with a total prescription/dose of not specified over not specified fractions. Chemotherapy drug was not specified. Immunotherapy was Not Used.\n",
      "\n",
      "The patient's response to treatment has been not specified, with tumor progression being Noted, occurring at the lateral margin of the right lateral ventricular atrium.\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  4.49it/s, est. speed input: 9747.0\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left frontal and temporal lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [31 years], and Karnofsky Performance Status (KPS) is [90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Absent], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [right anterior to mid corpus callosum, right anterior frontal lobe, and right caudate head].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [medial temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [80-90].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Used].\n",
      "\n",
      "The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left parahippocampal gyrus and hippocampus, left temporal stem and white matter, and left frontal lobe white matter].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporoparietal region], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [not specified]. The WHO grade is [IV]. The patient's age is [61 years], and Karnofsky Performance Status (KPS) is [60-80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Surgery Type, not specified], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [40 Gy] over [15] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Probable], occurring at [left temporoparietal region].\n",
      "The correct answer is NEGATIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [left temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [4.6 x 3.5 x 3.5 cm], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [33], and Karnofsky Performance Status (KPS) is [80-90]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Methylated], 1p/19q co-deletion [Not specified], ATRX status of [Not specified], TERT promoter mutation [Not specified], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable], with tumor progression being [Noted], occurring at [left temporal lobe].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in breast cancer at a major cancer hospital. Your task is to predict the 5-years survival outlook for a breast cancer patient\n",
      "            based on the following clinical notes, which represents the patient's status at 0.5 years (6 months) post-diagnosis.\n",
      "\n",
      "Here is a clinical notes summary example: \n",
      "The tumor was identified in the [Left hemisphere], specifically in the [posterior temporal lobe], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [50], and Karnofsky Performance Status (KPS) is [70-80]. Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [Unmethylated], 1p/19q co-deletion [not specified], ATRX status of [not specified], TERT promoter mutation [Present], and EGFR amplification [Absent]. The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [not specified] over [not specified] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [Stable, nonprogressive disease], with tumor progression being [Noted], occurring at [left superior frontal gyrus].\n",
      "The correct answer is POSITIVE.\n",
      "<|start_header_id|>user<|end_header_id|>You are an oncologist specializing in glioma at a major cancer hospital. Your task is to predict the 14-month survival outlook for a glioma patient\n",
      "                   based on the following clinical note summary at 0.5 years. Here is the summary: The tumor was identified in the [Left hemisphere], specifically in the [left temporoparietal lobes], and is characterized as [Glioblastoma]. The tumor measures [not specified], with a grade of [IV]. The WHO grade is [IV]. The patient's age is [85 years], and Karnofsky Performance Status (KPS) is [not specified].\n",
      "\n",
      "Key molecular markers include an IDH mutation status of [Non-mutant], MGMT promoter methylation status of [not specified], 1p/19q co-deletion [not specified], ATRX status of [Positive], TERT promoter mutation [Present], and EGFR amplification [Present].\n",
      "\n",
      "The patient had a [Subtotal Resection], followed by radiation therapy/radiotherapy/RT with a total prescription/dose of [60 Gy] over [30] fractions. Chemotherapy drug was [Temozolomide (TMZ)]. Immunotherapy was [Not Used]. The patient's response to treatment has been [not specified], with tumor progression being [Noted], occurring at [left frontal-temporal-parietal lobes].\n",
      "Based on your understanding of the clinical note summary for a glioma patient at 0.5 years, classify the 14-month survival outlook for this patient.\n",
      "                   Please respond with either POSITIVE or NEGATIVE<|eot_id|><|start_header_id|>assistant<|end_header_id|>The correct answer is \n",
      "Processed prompts: 100%|█| 1/1 [00:00<00:00,  5.08it/s, est. speed input: 9857.7\n",
      "Computing evaluation metrics...\n",
      "Evaluation complete. Metrics:\n",
      "  - Accuracy: 0.7320\n",
      "  - Precision: 0.7656\n",
      "  - Recall: 0.8167\n",
      "  - F1 Score: 0.7903\n",
      "  - AUC: 0.7802\n",
      "\n",
      "Metrics saved to evaluation_metrics_dynamic_summary.txt\n",
      "Script execution finished successfully.\n",
      "ERROR 02-21 13:48:33 multiproc_worker_utils.py:120] Worker VllmWorkerProcess pid 513349 died, exit code: -15\n",
      "INFO 02-21 13:48:33 multiproc_worker_utils.py:123] Killing local vLLM worker processes\n"
     ]
    }
   ],
   "source": [
    "!/home/srinivasb/.conda/envs/radoncB/bin/python3 run_dynamic_prompt.py \\\n",
    "    --exp_type dynamic_summary \\\n",
    "    --large False \\\n",
    "    --num_gpus 4 \\\n",
    "    --zero_shot False \\\n",
    "    --examples ../../example_summary_file.csv \\\n",
    "    --test_data ../../test_summary_file.csv \\\n",
    "    --summary True"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Results\n",
    "---"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
